document type sequence filename description text html head title title head body bgcolor white style margin margin bottom font size font family time roman align right exhibit style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width style font family time roman font size valign style border solid padding left padding right style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with style margin margin bottom font size font family time roman align center security exchange commission double asterisk denote omission style font size margin margin bottom align left nbsp table style margin margin bottom font size font family time roman align right final style margin margin bottom font size font family time roman align center collaboration license option agreement style margin margin bottom text indent font size font family time roman small small small ollaboration small small icense small small small small ption small small greement small small small agreement entered into january nbsp effective date between small urigene small small iscovery small small echnologies small small imited small small small company organized under india having address kiadb industrial area phase nbsp electronic city hosur road bangalore karnataka india aurigene small uris small nbsp small small corporation organized under delaware having address nbsp maguire road lexington massachusetts curis style margin margin bottom font size font family time roman align center small ecitals small style margin margin bottom text indent font size font family time roman small hereas small aurigene drug discovery preclinical development company seek find partner further development drug candidate meaningful relationship that will further long term interest having strategic stake development commercialization same style margin margin bottom text indent font size font family time roman small hereas small curis business clinical development commercialization drug with strategic focus immuno oncology precision oncology area style margin margin bottom text indent font size font family time roman small hereas small party desire establish collaborative relationship capitalizing their unique respective complementary capability expertise pursuant which among other thing style margin margin bottom text indent font size font family time roman party will select many program target profile mutual interest within immuno oncology precision oncology area feasible style margin margin bottom text indent font size font family time roman aurigene consultation with curis will conduct discovery research preclinical development with respect each such program target profile with goal identifying development candidate style margin margin bottom text indent font size font family time roman with respect each program target profile which aurigene identifies development candidate curis will have option obtain exclusive license develop commercialize such development candidate back program compound product curis territory style margin margin bottom text indent font size font family time roman curis exercise option with respect such program target profile aurigene will conduct enabling preclinical development support filing curis will responsible preparation filing conducting further development activity accordance with agreed development plan each party will responsible commercializing product respective territory style margin margin bottom font size font family time roman each case term subject condition forth herein style margin margin bottom text indent font size font family time roman small hereas small concurrently with execution this agreement party entering into stock purchase agreement dated effective date pursuant which curis issuing share curis common stock aurigene stock purchase agreement registration right agreement dated effective date with respect such share style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center small greement small style margin margin bottom text indent font size font family time roman small small small herefore small consideration foregoing premise mutual covenant contained herein other good valuable consideration receipt sufficiency which hereby acknowledged aurigene curis agree follows style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign small efinitions small small small table style margin margin bottom text indent font size font family time roman acceptance filing shall mean style margin margin bottom text indent font size font family time roman with respect filed product nbsp united state date into effect accordance with successor regulation nbsp other country group country after filing with applicable regulatory authority such country group country date upon which enrollment first subject applicable clinical trial such product legally occur such country group country style margin margin bottom text indent font size font family time roman with respect filed product nbsp united state receipt written notice from accordance with successor regulation that such officially filed nbsp major market either nbsp receipt written notice acceptance filing such from centralized filing procedure used nbsp receipt written notice acceptance filing such from applicable regulatory authority such major market centralized filing used nbsp japan receipt written notice acceptance filing such from mhlw style margin margin bottom text indent font size font family time roman accounting standard shall mean nbsp generally accepted accounting principle nbsp international financial reporting standard either case consistently applied throughout organization particular entity affiliate style margin margin bottom text indent font size font family time roman active program shall mean program with respect which given time least following true nbsp aurigene activity under plan such program ongoing nbsp after curis exercised option such program activity with respect program compound product from such program which aurigene responsible under development plan either ongoing been initiated provided however that initiation such activity under development plan failure curis perform obligation under development plan this agreement nbsp after curis exercised option with respect such program program compound product from such program being actively developed more curis affiliate curis sublicensee provided however that curis failure actively develop program compound product from such program failure aurigene perform obligation under development plan this agreement then such failure curis shall cause applicable program cease being considered active program nbsp after curis exercised option such program product from such program being actively commercialized major market more curis affiliate curis sublicensee style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman additional exclusivity period shall have meaning provided section nbsp style margin margin bottom text indent font size font family time roman additional shall have meaning provided section nbsp style margin margin bottom text indent font size font family time roman additional plan payment shall have meaning provided section nbsp style margin margin bottom text indent font size font family time roman additional program shall mean with respect additional program discovery research preclinical development aimed generating development candidate back program compound directed such additional style margin margin bottom text indent font size font family time roman additional program option shall have meaning provided section nbsp style margin margin bottom text indent font size font family time roman affiliate shall mean with respect company other business entity including party other company business entity controlled controlling under common control with such company other business entity purpose this definition term control including with correlative meaning term controlled under common control with shall mean possession directly indirectly more than outstanding voting security corporation comparable equity interest other type entity otherwise having power direct management policy such corporation other entity notwithstanding foregoing nbsp reddy laboratory subsidiary shall considered affiliate aurigene purpose this agreement style margin margin bottom text indent font size font family time roman applicable shall mean applicable provision national supranational regional state local treaty statute rule regulation administrative code guidance ordinance judgment decree directive injunction order permit from court arbitrator regulatory authority governmental agency authority having jurisdiction over related subject item including fcpa export control other comparable style margin margin bottom text indent font size font family time roman aurigene activity shall have meaning provided section nbsp style margin margin bottom text indent font size font family time roman aurigene immuno oncology shall have meaning provided section nbsp style margin margin bottom text indent font size font family time roman aurigene immuno oncology data package shall mean data package with respect aurigene immuno oncology style margin margin bottom text indent font size font family time roman aurigene invention shall mean invention made solely more employee consultant contractor aurigene style margin margin bottom text indent font size font family time roman aurigene know shall mean information controlled aurigene during term that necessary useful development manufacture commercialization program compound product including aurigene interest program invention joint invention style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman aurigene patent right shall mean patent right controlled aurigene during term that cover claim invention that necessary useful development manufacture commercialization program compound product including aurigene interest program patent right joint patent right style margin margin bottom text indent font size font family time roman aurigene exclusivity obligation shall mean with respect particular program target profile aurigene obligation under section nbsp with respect such program target profile curis right under section nbsp with respect follow molecule such program target profile style margin margin bottom text indent font size font family time roman aurigene technology shall mean aurigene know aurigene patent right style margin margin bottom text indent font size font family time roman aurigene territory shall mean republic india russian federation style margin margin bottom text indent font size font family time roman aurigene territory license shall have meaning provided section nbsp style margin margin bottom text indent font size font family time roman activity shall mean with respect development candidate drug substance activity necessary generate chemistry manufacturing control section equivalent filing style margin margin bottom text indent font size font family time roman collaboration scope shall mean immuno oncology precision oncology style margin margin bottom text indent font size font family time roman combination product shall mean product that sold finished dosage form containing program compound combination with more other active style margin margin bottom text indent font size font family time roman commercially reasonable effort shall mean with respect party effort perform obligation with respect discovery research development commercialization program compound development candidate product under this agreement diligent sustained effort commensurate with level effort that pharmaceutical biotechnology company exercise reasonable business judgment would commonly devote compound product similar market potential profit potential similar stage development product life resulting from research effort based condition then prevailing taking into account without limitation issue safety efficacy regulatory authority approved labeling product profile competitiveness alternative product marketplace likely timing product entry into market patent other proprietary position other relevant scientific technical commercial factor payment aurigene under this agreement shall considered evaluating curis obligation commercially reasonable effort addition other compound product owned licensed party shall considered evaluating party obligation commercially reasonable effort commercially reasonable effort require without limitation that party exerting such effort nbsp promptly assign responsibility obligation specific employee contractor held accountable progress monitor such progress ongoing basis nbsp continue seek achieve specific meaningful objective carrying such obligation nbsp consistently make implement decision allocate resource designed advance progress with respect such objective each case commercially reasonable manner addition stopping material work program more than four nbsp consecutive month other than required applicable regulatory authority shall considered commercially reasonable effort style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman competing program shall mean with respect particular program target profile research development program other than program such program target profile that directed compound primary mechanism action which modulation such program target profile compound that would program compound generated under such program style margin margin bottom text indent font size font family time roman compound shall mean molecule generated aurigene performance program previously generated aurigene specifically designated aurigene study program style margin margin bottom text indent font size font family time roman confidential information party shall mean subject exception forth section nbsp confidential proprietary information including information that disclosed made available behalf such party disclosing party other party receiving party receiving party representative connection with this agreement whether writing orally visually otherwise including nbsp proprietary information such term defined mutual disclosed made available behalf such party other party representative pursuant mutual nbsp case aurigene proprietary structure information such term defined mutual confidential information such term defined supplemental disclosed made available behalf aurigene curis representative pursuant mutual supplemental respectively notwithstanding foregoing party agree that joint invention shall considered confidential information both party purpose this agreement each party shall considered receiving party with respect thereto style margin margin bottom text indent font size font family time roman control controlled shall mean with respect information patent right other intellectual property right possession entity ability whether ownership license otherwise grant access grant grant license sublicense under such information patent right intellectual property right without violating term agreement other arrangement with third party style margin margin bottom text indent font size font family time roman create mean leahy smith america invents nbsp style margin margin bottom text indent font size font family time roman curis data shall mean data result research preclinical clinical stability toxicology other study program compound product conducted behalf curis during term clarity study conducted under direction aurigene considered study conducted behalf curis style margin margin bottom text indent font size font family time roman curis invention shall mean invention made solely more employee consultant contractor curis style margin margin bottom text indent font size font family time roman curis know shall mean information controlled except virtue license granted curis under this agreement curis during term that necessary useful development manufacture commercialization program compound product including curis data curis interest program invention joint invention style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman curis sale shall have meaning provided section nbsp style margin margin bottom text indent font size font family time roman curis patent right shall mean patent right controlled except virtue license granted curis under this agreement curis during term that cover claim invention that necessary useful development manufacture commercialization program compound product including curis interest program patent right joint patent right style margin margin bottom text indent font size font family time roman curis technology shall mean curis know curis patent right style margin margin bottom text indent font size font family time roman curis territory shall mean entire world excluding aurigene territory style margin margin bottom text indent font size font family time roman data package shall mean with respect either aurigene immuno oncology follow molecule profile applicable package containing style margin margin bottom text indent font size font family time roman data other information regarding proposed target molecular profile such aurigene immuno oncology follow molecule profile including intended mode action potential program compound font style white space nowrap follow font molecule applicable generated generated broad pharmacokinetic pharmacodynamic efficacy safety parameter that expected achieved well proposed medicinal chemistry approach generating program compound follow molecule applicable with estimated timeline development candidate identification style margin margin bottom text indent font size font family time roman data regarding compound discovered generated aurigene such aurigene immuno oncology follow molecule profile that demonstrate least following style margin margin bottom text indent font size font family time roman target cellular activity cellular pharmacodynamic readout style margin margin bottom text indent font size font family time roman selectivity against related target style margin margin bottom text indent font size font family time roman nbsp vivo exposure sufficient achieve target modulation style margin margin bottom text indent font size font family time roman data package review period shall mean with respect aurigene immuno oncology data package follow molecule profile data package period nbsp from delivery such data package curis subject extension curis reasonable request aurigene approval which shall unreasonably withheld additional nbsp reasonably necessary nbsp curis nbsp review such data package event that includes substantial data information that previously been disclosed curis otherwise nbsp conduct appropriate patentability analysis freedom operate search with respect compound described such data package nbsp address other bona fide scientific intellectual property question concern raised curis during period after delivery such data package notwithstanding foregoing curis determines during font style white space nowrap font period after delivery such data package that such information delivered aurigene constitute data package defined style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman section nbsp then curis shall promptly call meeting held within aurigene delivery purported data package unanimously reach determination such meeting whether information delivered aurigene constitutes data package defined section nbsp then party shall submit matter independent third party expert with least year experience pharmaceutical industry practice with respect development pharmaceutical product resolution which expert shall agreed upon both party failing such agreement designated international centre dispute resolution located york city sole authority such expert will determine whether information delivered aurigene constitutes data package defined section nbsp such expert determination shall final binding upon party independent third party expert shall required make determination within after selection independent third party expert party shall initially bear expense such expert equally prevailing party shall reimburse other party documented expense such expert paid prevailing party data package review period shall tolled during above dispute resolution procedure determined either independent third party expert that information delivered aurigene constitute data package then data package review period shall begin until aurigene delivers sufficient information constitute data package style margin margin bottom text indent font size font family time roman development candidate shall mean with respect program lead candidate that meet target molecular profile criterion forth plan such program selected advancement enabling study style margin margin bottom text indent font size font family time roman development candidate data package shall have meaning provided section nbsp style margin margin bottom text indent font size font family time roman development plan shall have meaning provided section nbsp style margin margin bottom text indent font size font family time roman disclosing party shall have meaning provided section nbsp style margin margin bottom text indent font size font family time roman shall mean european medicine agency successor agency thereto having administrative authority regulate marketing human pharmaceutical product style margin margin bottom text indent font size font family time roman shall mean european union style margin margin bottom text indent font size font family time roman exclusive program target profile shall mean program target profile which given date there active program style margin margin bottom text indent font size font family time roman exclusivity option shall have meaning provided section nbsp style margin margin bottom text indent font size font family time roman exclusivity period shall mean initial exclusivity period applicable each additional exclusivity period which curis timely applicable exclusivity option avoidance doubt excluding extended exclusivity period style margin margin bottom text indent font size font family time roman executive shall have meaning provided section nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman export control shall mean applicable regulation relating nbsp sanction embargo imposed office foreign asset control department treasury nbsp export export commodity technology service including export administration international emergency economic power trading with enemy export control international boycott provision section nbsp internal revenue code amended style margin margin bottom text indent font size font family time roman extended exclusivity shall have meaning provided section nbsp style margin margin bottom text indent font size font family time roman extended exclusivity period shall have meaning provided section nbsp style margin margin bottom text indent font size font family time roman fcpa shall mean foreign corrupt practice section nbsp amended style margin margin bottom text indent font size font family time roman shall mean food drug administration successor agency thereto having administrative authority regulate marketing human pharmaceutical product style margin margin bottom text indent font size font family time roman field shall mean style margin margin bottom text indent font size font family time roman first commercial sale shall mean first sale product curis affiliate sublicensees third party consumption such product country after applicable regulatory authority such country granted regulatory approval such product style margin margin bottom text indent font size font family time roman follow molecule shall mean with respect program which curis exercised option molecule style margin margin bottom text indent font size font family time roman primary mechanism action which modulation program target profile such program style margin margin bottom text indent font size font family time roman that program compound from such program style margin margin bottom text indent font size font family time roman composition matter which covered aurigene patent right style margin margin bottom text indent font size font family time roman follow molecule data package shall mean data package with respect follow molecule profile style margin margin bottom text indent font size font family time roman follow molecule profile shall mean program target profile with respect which aurigene conduct research discovery follow molecule during exclusivity period case exclusive program target profile extended exclusivity period style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman shall mean then current good clinical practice such term defined from time time other regulatory authority competent jurisdiction pursuant regulation guideline otherwise applicable style margin margin bottom text indent font size font family time roman generic version shall mean with respect product country country basis pharmaceutical product that nbsp sold given country third party other than curis affiliate sublicensee other third party chain distribution originating from curis affiliate sublicensee nbsp contains same program compound such product fixed dose combination that also contains other active pharmaceutical ingredient that program compound same other active ingredient such product same dosage form strength each active ingredient route administration such product nbsp been approved marketing relevant regulatory authority such country reliance marketing approval such product such country including such pharmaceutical product that been approved marketing nbsp pursuant section nbsp section nbsp respectively nbsp member state generic medicinal product pursuant article nbsp parliament council directive amended including application under article nbsp parliament council regulation that relies content such provision nbsp other country jurisdiction pursuant equivalent foregoing regulation directive wherein approval such pharmaceutical product based reference marketing approval such product such country demonstration equivalence such product each case which substituted product without action physician health care practitioner style margin margin bottom text indent font size font family time roman shall mean then current good laboratory practice such term defined from time time other regulatory authority competent jurisdiction pursuant regulation guideline otherwise applicable style margin margin bottom text indent font size font family time roman shall mean then current good manufacturing practice such term defined from time time other regulatory authority competent jurisdiction pursuant regulation guideline otherwise applicable style margin margin bottom text indent font size font family time roman governmental authority mean government other nation political subdivision thereof whether state local agency authority instrumentality regulatory body court central bank other entity exercising executive legislative judicial taxing regulatory administrative power function pertaining government including supra national body such european central bank style margin margin bottom text indent font size font family time roman shall mean hart scott rodino antitrust improvement amended rule regulation promulgated thereunder style margin margin bottom text indent font size font family time roman mean international conference harmonisation technical requirement registration pharmaceutical human style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman immuno oncology shall mean modulation immuno modulating target that primarily involve cell interaction whether with other immune cell tumor cell cell tumor microenvironment style margin margin bottom text indent font size font family time roman shall mean investigational drug application filed with equivalent application filing filed with equivalent regulatory authority outside including supra national agency such necessary commence human clinical trial such jurisdiction style margin margin bottom text indent font size font family time roman indication shall mean specific disease disorder condition bearing distinct reference number under defined department health human service indication have distinct reference number when first three number reference different example acute post operative pain bear reference number acute pain trauma bear reference number these would considered different indication comparison diabetic neuropathy bear reference number post herpetic neuralgia bear reference number these would considered different indication further clarification treatment disease disorder condition particular patient population treatment same disease disorder condition different population adult population pediatric population will treated separate indication style margin margin bottom text indent font size font family time roman information shall mean tangible intangible nbsp technique technology practice trade secret invention whether patentable method knowledge know skill experience test data result including pharmacological toxicological clinical test data result analytical quality control data result description software algorithm nbsp composition matter cell cell line assay animal model physical biological chemical material style margin margin bottom text indent font size font family time roman initial exclusivity period shall mean period beginning effective date expiring earlier nbsp nbsp month from effective date nbsp nbsp after achievement initial immuno oncology clinical milestone style margin margin bottom text indent font size font family time roman initial immuno oncology clinical milestone shall mean determined first demonstration target pharmacodynamic activity more than human subject using program compound directed product target profile immuno oncology style margin margin bottom text indent font size font family time roman initial ownership percentage shall have meaning provided section nbsp style margin margin bottom text indent font size font family time roman initial shall mean style margin margin bottom text indent font size font family time roman initiation human clinical trial shall mean first dosing whether investigational product placebo comparator fifth subject dosed such trial style margin margin bottom text indent font size font family time roman invention shall mean invention whether patentable made course result conduct activity contemplated this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman joint invention shall mean invention made jointly more employee consultant contractor aurigene more employee consultant contractor curis style margin margin bottom text indent font size font family time roman joint patent right shall mean patent right that cover claim joint invention style margin margin bottom text indent font size font family time roman lead candidate shall mean with respect program program compound that meet criterion forth plan such program that determines warrant further advancement with goal qualification development candidate style margin margin bottom text indent font size font family time roman license shall have meaning provided section nbsp style margin margin bottom text indent font size font family time roman licensed program shall have meaning provided section nbsp style margin margin bottom text indent font size font family time roman major market shall mean nbsp following country france germany italy spain united kingdom nbsp whole style margin margin bottom text indent font size font family time roman major market shall mean following country major market japan style margin margin bottom text indent font size font family time roman mhlw shall mean japanese ministry health labour welfare koseisho successor agency thereto style margin margin bottom text indent font size font family time roman mutual shall mean that certain mutual confidential disclosure agreement between party dated february nbsp amended that certain amendment mutual confidential disclosure agreement dated october nbsp that certain second amendment mutual confidential disclosure agreement dated november nbsp style margin margin bottom text indent font size font family time roman shall mean nbsp drug application more fully defined nbsp successor regulation thereto nbsp equivalent application filed with equivalent regulatory authority outside including each case amendment supplement thereto style margin margin bottom text indent font size font family time roman sale shall mean gross amount invoiced sale other disposition product behalf curis affiliate sublicensee each selling party third party other than selling party following deduction actually incurred allowed paid accrued otherwise specifically allocated product selling party previously deducted calculating amount invoiced compliance with applicable accounting standard consistently applied selling party style margin margin bottom text indent font size font family time roman normal customary trade discount including trade cash quantity discount rebate credit actually allowed taken style margin margin bottom text indent font size font family time roman credit refund allowance actually granted made rejection return previously sold product including recall retroactive price reduction billing error style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman governmental other rebate credit other equivalent thereof actually granted managed health care organization commercial insurance company pharmacy benefit manager equivalent thereof distributor national state provincial local other government their agency purchaser reimbursers trade customer style margin margin bottom text indent font size font family time roman reasonable customary paid wholesaler group purchasing organization third party payors managed care entity each case based sale dispensing product style margin margin bottom text indent font size font family time roman charge separately invoiced customer freight insurance transportation postage handling style margin margin bottom text indent font size font family time roman custom duty other governmental charge including such value added similar government charge excluding what commonly known income levied measured billing amount product adjusted rebate refund each case separately invoiced customer style margin margin bottom text indent font size font family time roman event shall particular amount identified above deducted more than once calculating sale double counting deduction style margin margin bottom text indent font size font family time roman clarification sale product selling party another selling party resale such entity third party other than selling party shall deemed sale purpose this definition sale provided that subsequent resale included computation sale further transfer disposition product without consideration nbsp connection with patient assistance program nbsp charitable promotional purpose nbsp preclinical clinical regulatory governmental purpose under called named patient other limited access program nbsp test study reasonably necessary comply with applicable regulation request regulatory authority shall each case nbsp through deemed sale such product purpose this definition sale style margin margin bottom text indent font size font family time roman country country basis product under this agreement sold form combination product country sale purpose determining royalty hereunder shall calculated follows style margin margin bottom text indent font size font family time roman where both product containing program compound sole active pharmaceutical ingredient mono product other active such combination product sold separately such country sale shall calculated multiplying actual sale such combination product such country determined under first paragraph this section nbsp fraction where invoice price mono product such country invoice price other active combination when sold separately such country style margin margin bottom text indent font size font family time roman mono product sold such country none other active sold separately such country sale shall calculated multiplying actual sale such combination product such country determined under first paragraph this section nbsp fraction where invoice price such mono product such country invoice price combination product such country style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman mono product sold separately such country other active sold separately such country sale shall calculated multiplying actual sale such combination product such country determined under first paragraph this section nbsp fraction where invoice price combination product such country invoice price charged other active combination product when sold separately such country style margin margin bottom text indent font size font family time roman neither mono product other active sold separately such country sale purpose determining royalty hereunder combination product shall determined mutual agreement party good faith taking into account relative value contribution program compound portion combination product other active combination product provided however that event shall relative value contribution program compound portion combination product than case disagreement independent expert agreed upon both party failing such agreement designated international centre dispute resolution located york city shall determine such relative value contribution such determination shall final binding upon party style margin margin bottom text indent font size font family time roman royalty sublicense revenue shall mean with respect particular licensed program amount actually received curis affiliate from particular sublicensee consideration grant such sublicensee sublicense under license granted aurigene curis with respect such licensed program without limiting generality foregoing royalty sublicense revenue shall include front license milestone payment subject section nbsp technology access premium above fair market value sale debt equity security curis affiliate annual maintenance other payment attributable grant such sublicensee sublicense under license such licensed program however royalty sublicense revenue shall exclude nbsp sublicensee royalty nbsp bona fide research development funding received from sublicensee curis affiliate employee performance specified research development work funding after date sublicense which calculated fully burdened basis reimbursement such sublicensee documented external cost incurred curis affiliate after date sublicense specialized material except standard material cost included curis affiliate fully burdened rate specialized equipment third party service each case specifically such specified research development work nbsp payment equity security curis affiliate that below fair market value such security date receipt determined good faith curis affiliate board director such security then traded public security exchange determined closing price such security curis affiliate applicable date receipt such security then traded public security exchange nbsp payment debt security curis affiliate except extent such debt forgiven cancelled other than exchange payment full whether cash kind nbsp payment reimbursement sublicensee patent cost actually incurred curis affiliate after date sublicense with respect patent right under license granted aurigene curis with respect licensed program sublicensed sublicensee style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman option shall mean program option additional program option applicable style margin margin bottom text indent font size font family time roman option period shall have meaning provided section nbsp subject section nbsp applicable style margin margin bottom text indent font size font family time roman other active shall mean active pharmaceutical ingredient that program compound style margin margin bottom text indent font size font family time roman party shall mean aurigene curis individually party shall mean aurigene curis collectively style margin margin bottom text indent font size font family time roman patent right shall mean nbsp patent examination reissue renewal extension term restoration supplementary protection certificate like filing thereof nbsp pending application patent including provisional application continuation continuation part divisional substitute application including confirmation patent registration patent patent addition inventor certificate foreign counterpart thereof style margin margin bottom text indent font size font family time roman person shall mean individual partnership joint venture limited liability company corporation firm trust association unincorporated organization governmental authority agency other entity specifically listed herein style margin margin bottom text indent font size font family time roman phase nbsp trial shall mean human clinical trial that would satisfy requirement phase nbsp study defined nbsp nbsp amended successor regulation style margin margin bottom text indent font size font family time roman phase nbsp trial shall mean human clinical trial that would satisfy requirement phase nbsp study defined nbsp nbsp amended successor regulation style margin margin bottom text indent font size font family time roman phase nbsp trial shall mean human clinical trial that would satisfy requirement phase nbsp study defined nbsp nbsp amended successor regulation style margin margin bottom text indent font size font family time roman pierre fabre agreement shall mean that certain collaborative license development commercialization agreement between aurigene pierre fabre dated february nbsp amended date style margin margin bottom text indent font size font family time roman pivotal trial shall mean nbsp phase nbsp trial nbsp other human clinical trial that applicable regulatory authority agreed whether before first dosing first patient such trial nbsp pursuant special protocol assessment agreement with after first dosing first patient such trial based interim data analysis sufficient form primary basis efficacy claim submission regardless whether sponsor such trial characterizes refers such trial phase nbsp phase nbsp phase nbsp trial otherwise applicable protocol clinicaltrials other context human clinical trial constitute pivotal trial time first dosing first patient such trial later determined applicable regulatory style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman authority sufficient form primary basis efficacy claim submission then purpose section nbsp hereof notwithstanding section nbsp hereof initiation such pivotal trial shall deemed have occurred date such determination applicable regulatory authority style margin margin bottom text indent font size font family time roman precision oncology shall mean molecular target mutually agreed between party included therapeutic strategy modulate activity cellular protein whose encoding gene altered mutation amplification translocation population human cancer irak considered precision oncology target style margin margin bottom text indent font size font family time roman product shall mean pharmaceutical composition preparation containing comprising program compound whether sole active ingredient including each case formulation dosage form thereof style margin margin bottom text indent font size font family time roman program shall mean program additional program style margin margin bottom text indent font size font family time roman program compound shall mean with respect program target profile compound primary mechanism action which demonstrated biochemical pharmacologic assay including cell based nbsp vivo relevant modulation such program target profile with respect primary mechanism action only such program target profile style margin margin bottom text indent font size font family time roman program invention shall mean nbsp aurigene invention curis invention that made under program nbsp joint invention that made under program style margin margin bottom text indent font size font family time roman program know shall mean information generated behalf aurigene curis jointly behalf aurigene curis under program including program invention style margin margin bottom text indent font size font family time roman program patent right shall mean patent right claiming program invention style margin margin bottom text indent font size font family time roman program target profile shall mean protein gene target selected party whose activity intended specifically modulated using compound forth plan program style margin margin bottom text indent font size font family time roman program technology shall mean program patent right program know style margin margin bottom text indent font size font family time roman shall mean irak style margin margin bottom text indent font size font family time roman shall mean nbsp pathway style margin margin bottom text indent font size font family time roman shall mean first program target profile other than selected curis applicable after effective date pursuant section nbsp style margin margin bottom text indent font size font family time roman shall mean first program target profile selected curis applicable pursuant section nbsp after selection style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman plan shall mean have meaning provided section nbsp style margin margin bottom text indent font size font family time roman program shall mean with respect each initial program discovery research preclinical development aimed generating development candidate back program compound directed applicable program target profile style margin margin bottom text indent font size font family time roman program option shall have meaning provided section nbsp style margin margin bottom text indent font size font family time roman receiving party shall have meaning provided section nbsp style margin margin bottom text indent font size font family time roman regulatory approval shall mean approval including price reimbursement approval required marketing sale license registration authorization regulatory authority that necessary manufacture storage import transport sale product country other regulatory jurisdiction style margin margin bottom text indent font size font family time roman regulatory authority shall mean national supranational other regulatory agency department bureau other governmental regulatory authority having administrative authority regulate development marketing pharmaceutical product country other jurisdiction including mhlw style margin margin bottom text indent font size font family time roman regulatory filing mean drug dossier master file filed regulatory approval obtained with respect product program compound including amendment supplement annual report like filed otherwise provided applicable regulatory authority style margin margin bottom text indent font size font family time roman representative party shall mean such party officer director employee consultant style margin margin bottom text indent font size font family time roman research term shall mean period beginning upon recommendation research plan first program subject earlier termination this agreement expiring upon completion aurigene obligation under plan style margin margin bottom text indent font size font family time roman royalty term shall have meaning provided section nbsp style margin margin bottom text indent font size font family time roman shall have meaning provided section nbsp style margin margin bottom text indent font size font family time roman sublicensee shall mean with respect particular licensed program third party sublicensee under license granted aurigene curis with respect such licensed program whether such third party sublicense granted directly curis affiliate indirectly through more tier sublicense style margin margin bottom text indent font size font family time roman sublicensee royalty shall mean licensed program licensed program sublicensee sublicensee basis royalty received curis affiliate sale other disposition product from such licensed program each sublicensee further sublicensees style margin margin bottom text indent font size font family time roman supplemental shall mean that certain supplemental nondisclosure agreement between party dated november nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman target molecular profile shall have meaning provided section nbsp style margin margin bottom text indent font size font family time roman target product profile shall have meaning provided section nbsp style margin margin bottom text indent font size font family time roman shall mean present future income stamp other levy impost duty deduction charge withholding imposed governmental authority including interest penalty thereon style margin margin bottom text indent font size font family time roman term shall have meaning provided section nbsp style margin margin bottom text indent font size font family time roman terminated program shall mean style margin margin bottom text indent font size font family time roman case termination this agreement entirety aurigene pursuant section nbsp program that licensed program immediately prior such termination excluding other than termination under section nbsp uncured material payment breach such licensed program which initiation first pivotal trial product occurred prior such termination style margin margin bottom text indent font size font family time roman case termination this agreement particular licensed program aurigene either pursuant section nbsp extent said section permit termination such licensed program pursuant section nbsp such licensed program style margin margin bottom text indent font size font family time roman case termination this agreement entirety curis pursuant section nbsp program that licensed program immediately prior such termination style margin margin bottom text indent font size font family time roman case termination this agreement particular licensed program curis pursuant section nbsp such licensed program style margin margin bottom font size font family time roman provided however that case paragraph nbsp nbsp above curis termination this agreement entirety particular licensed program pursuant section nbsp with respect only particular country subset country within curis territory applicable terminated region applicable licensed program shall considered terminated program only terminated region shall remain licensed program rest curis territory style margin margin bottom text indent font size font family time roman terminated region shall have meaning provided section nbsp style margin margin bottom text indent font size font family time roman territory shall mean aurigene territory curis territory style margin margin bottom text indent font size font family time roman third party shall mean person other than aurigene affiliate curis affiliate style margin margin bottom text indent font size font family time roman upfront equity issuance shall have meaning provided section nbsp style margin margin bottom text indent font size font family time roman shall mean united state america style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman valid claim shall mean claim contained nbsp issued unexpired patent which been held unenforceable unpatentable invalid decision court other governmental agency competent jurisdiction unappealable unappealed within time allowed appeal which been admitted invalid unenforceable through abandonment reissue disclaimer otherwise nbsp patent application that been irretrievably cancelled withdrawn abandoned that been pending than year from filing date from which such claim take priority claim patent application that ceased valid claim under clause nbsp preceding sentence because passage time later issue part patent within clause nbsp preceding sentence then shall again considered valid claim effective issuance such patent style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign small teering small small small small versight small small ommittee small small small table style margin margin bottom text indent font size font family time roman formation composition within nbsp after effective date party shall establish steering oversight committee composed nbsp representative each aurigene curis each party change representative from time time sole discretion effective upon notice other party such change these representative shall have appropriate technical credential experience knowledge authority within such party organization however party acknowledge agree that will rely opinion expert employee specializing leading relevant discipline aurigene curis well expert consultant advisor employed either party support research discovery development commercialization program compound will jointly chaired party with each party designating representative chairperson chairperson shall agenda meeting advance provided that agenda will include matter requested either party reasonable number additional representative party attend meeting voting capacity after establishment shall remain place until completion clinical development last program compound product excluding clinical trial reasonably necessary obtaining maintaining regulatory approval program compound product style margin margin bottom text indent font size font family time roman responsibility authority overall responsibility shall oversee encourage facilitate ongoing cooperation communication between party regarding program further development development candidate perform other obligation specifically delegated this agreement subject limitation forth this article nbsp particular shall style margin margin bottom text indent font size font family time roman meet periodically discus proposed ptps selection program target profile aurigene generate conduct plan style margin margin bottom text indent font size font family time roman review initial plan each program thereafter periodically review such plan subject section nbsp update amend such plan needed from time time style margin margin bottom text indent font size font family time roman review initial target molecular profile criterion program compound designation development candidate review update amendment thereto from time time style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman review result activity under each plan determine whether particular program compound meet applicable lead candidate criterion development candidate criterion forth such plan style margin margin bottom text indent font size font family time roman discus technical feasibility issue that arise performance plan consider whether amendment such plan necessary advisable style margin margin bottom text indent font size font family time roman subject section nbsp review discus initial development plan generated curis each licensed program style margin margin bottom text indent font size font family time roman provide forum review discussion initial target product profile criterion licensed program style margin margin bottom text indent font size font family time roman provide forum aurigene keep curis reasonably informed progress result aurigene discovery research activity with respect aurigene immuno oncology ptps follow molecule profile style margin margin bottom text indent font size font family time roman review each aurigene immuno oncology data package follow molecule data package development candidate data package within time period requested alliance manager prior expiration relevant data package review period option period determine whether information submitted sufficient meet requirement aurigene immuno oncology data package follow molecule data package development candidate data package such information determined meet requirement applicable data package identify data information necessary meet such requirement style margin margin bottom text indent font size font family time roman provide forum review discussion nbsp result plan activity including data information included each development candidate data package delivered aurigene nbsp data information included each aurigene immuno oncology data package follow molecule data package generated aurigene nbsp result development plan activity conducted curis nbsp update curis with respect contemplated change development plan nbsp update curis with respect expected resource requirement contemplated development activity other than those performed aurigene style margin margin bottom text indent font size font family time roman review publication strategy with respect program technology contemplated section nbsp style margin margin bottom text indent font size font family time roman perform such other duty outlined this agreement style margin margin bottom text indent font size font family time roman each party shall responsible ensuring that time representative reasonably good faith carrying their respective responsibility hereunder style margin margin bottom text indent font size font family time roman meeting shall meet deemed necessary member otherwise required term this agreement least time year until selection least every month thereafter during research term least thereafter long there least active program with location such meeting style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman alternating between aurigene curis facility such other location mutually agreed party alternatively meet mean teleconference videoconference other similar communication equipment each party shall responsible expense participating meeting style margin margin bottom text indent font size font family time roman minute responsibility preparing definitive minute each meeting shall alternate between party responsible party shall circulate draft minute each meeting member comment within nbsp after such meeting such minute shall provide description reasonable detail discussion meeting shall document action taken recommendation made such meeting including selection program target profile review plan amendment thereto determination that lead candidate development candidate been identified initiation program follow molecule profile description target product profile development plan relating program addition event recommendation meeting plan development plan amendment either foregoing such plan development plan amendment shall attached minute exhibit party shall promptly discus comment such minute finalize minute later than date next meeting style margin margin bottom text indent font size font family time roman recommendation recommendation shall made unanimous vote with each party representative collectively having vote cast good faith vote taken unless least each party representative present vote authority shall limited those matter expressly delegated this agreement without limiting generality foregoing neither either party exercise breaking authority under section nbsp shall have right power authority style margin margin bottom text indent font size font family time roman determine issue manner that would conflict with express term condition this agreement style margin margin bottom text indent font size font family time roman determine manner which party performs obligation under plan development plan financial human other resource devoted party plan development plan activity style margin margin bottom text indent font size font family time roman modify amend term condition this agreement style margin margin bottom text indent font size font family time roman dispute resolution reach consensus with regard recommendation other matter within authority within nbsp after such matter been brought attention then such matter shall referred chief executive officer aurigene chief executive officer curis provided each case that neither them current representative applicable party their respective designees with decision making authority neither whom current representative applicable party executive shall promptly meet attempt good faith resolve such matter within nbsp executive resolve such matter within nbsp date such matter first referred them then subject section nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman aurigene shall have breaking vote well overall decision making authority with respect functional responsibility pertaining nbsp aurigene activity under plan nbsp except expressly forth section nbsp aurigene conduct enabling study under development plan style margin margin bottom text indent font size font family time roman curis shall have breaking vote well overall decision making authority with respect nbsp selection particular potential particular aurigene immuno oncology which aurigene generates aurigene immuno oncology data package program target profile nbsp definition lead candidate criterion target molecular profile each plan nbsp target product profile each licensed program style margin margin bottom font size font family time roman provided however that each case party having breaking vote shall give good faith consideration other party position make reasonable effort take other party position into account making decision addition notwithstanding other provision this agreement contrary unanimous recommendation both party representative without resort either party breaking authority will required mutual agreement each party shall required style margin margin bottom text indent font size font family time roman select precision oncology program target profile style margin margin bottom text indent font size font family time roman select program target profile outside collaboration scope style margin margin bottom text indent font size font family time roman resolve dispute referred patent team with respect licensed program aurigene shall have final decision making authority resolve dispute patent team with respect aurigene patent right program prior exercise option curis such program style margin margin bottom text indent font size font family time roman alliance manager within nbsp after effective date each party shall appoint representative alliance manager facilitate ongoing communication exchange information between party liaison between party alliance manager will responsible establishing monitoring method secure electronic data exchange between party each party replace alliance manager time upon notice other party style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign small ollaboration small small small table style margin margin bottom text indent font size font family time roman program target profile style margin margin bottom text indent font size font family time roman effective date party have selected program target profile first program conducted under this agreement style margin margin bottom text indent font size font family time roman program target profile proposal selection style margin margin bottom text indent font size font family time roman party from time time during exclusivity period party discretion during extended exclusivity period either style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman party propose specific protein gene target within collaboration scope mutually agreed party outside collaboration scope either case proposed potential selection program target profile conduct style margin margin bottom text indent font size font family time roman program case style margin margin bottom text indent font size font family time roman additional program case program target profile other than initial additional style margin margin bottom text indent font size font family time roman shall promptly consider each proposed determine whether recommend selection thereof program target profile conduct program additional program applicable style margin margin bottom text indent font size font family time roman aurigene addition during exclusivity period aurigene conduct drug discovery research program directed potential program target profile immuno oncology aurigene immuno oncology aurigene shall provide regular update curis regarding progress result such aurigene immuno oncology program such time aurigene generated aurigene immuno oncology data package such potential aurigene immuno oncology aurigene shall promptly deliver such aurigene immuno oncology data package curis during applicable data package review period aurigene shall make qualified aurigene representative reasonably available curis meeting otherwise discussion such aurigene immuno oncology data package curis shall have until expiration applicable data package review period elect whether such aurigene immuno oncology program target profile conduct program additional program applicable curis informs aurigene that decline select such aurigene immuno oncology program target profile program curis fails inform aurigene curis decision regarding such aurigene immuno oncology prior expiration such data package review period aurigene exclusivity obligation with respect solely such aurigene immuno oncology shall cease style margin margin bottom text indent font size font family time roman timing selection party shall commercially reasonable effort recommend selection accordance with section nbsp prior initial exclusivity period alternatively during initial exclusivity period prior recommendation selection both aurigene generates aurigene immuno oncology data package with respect aurigene immuno oncology curis select such aurigene immuno oncology applicable curis acknowledges that recommendation curis selection applicable proposed aurigene immuno oncology shall subject program selection payment obligation forth section nbsp style margin margin bottom text indent font size font family time roman additional program curis acknowledges that recommendation curis selection applicable proposed aurigene immuno oncology additional conduct additional program shall subject additional plan payment obligation forth section nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman plan first meeting case promptly practicable event within nbsp after nbsp recommendation selection curis selection applicable additional nbsp curis election initiate program follow molecule particular program target profile pursuant section nbsp shall review recommend subject each party final approval aspect that within such party final decision making authority pursuant section written plan applicable program conducted with respect such program target profile each plan which shall subject amendment from time time accordance with article nbsp each plan shall style margin margin bottom text indent font size font family time roman identify applicable program target profile style margin margin bottom text indent font size font family time roman forth style margin margin bottom text indent font size font family time roman specific discovery research preclinical activity undertaken part program such program target profile style margin margin bottom text indent font size font family time roman criterion lead candidate selection style margin margin bottom text indent font size font family time roman chemical biochemical pharmacologic activity including limited cell based nbsp vivo modulating such program target profile well pharmacokinetic pharmacodynamic stability safety property that program compound expected have order qualify selection development candidate back program compound target molecular profile style margin margin bottom text indent font size font family time roman used herein term plan shall mean plan then effect including update amendment thereto made accordance with term this agreement style margin margin bottom text indent font size font family time roman aurigene diligence program program basis aurigene shall commercially reasonable effort conduct each program expeditious manner generate least lead candidate from each program present least development candidate from each program deliver curis corresponding development candidate data package provided however that style margin margin bottom text indent font size font family time roman foregoing diligence obligation with respect program each subject curis payment when lead candidate selection milestone payment such program accordance with section nbsp style margin margin bottom text indent font size font family time roman foregoing diligence obligation with respect each additional program subject curis payment when additional plan payment such additional program accordance with section nbsp style margin margin bottom text indent font size font family time roman event that despite conducting activity which responsible under particular plan using commercially reasonable effort generate lead candidate applicable program target profile aurigene unable generate lead candidate such program target profile aurigene shall promptly call meeting held within nbsp thereof which aurigene shall present style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman relevant data information with respect compound generated performance such plan shall discus good faith technical feasibility issue encountered aurigene effort generate lead candidate such program target profile review lead candidate criterion under such plan consider whether amendment such plan whether provide aurigene perform additional activity modify lead candidate criterion forth therein otherwise necessary advisable party shall cooperate good faith with recommendation perform additional activity including more third party selected effort generate lead candidate with cost borne agreed party such meeting within nbsp after completion such additional activity determined lead candidate been generated select further activity undertaken effort generate lead candidate then curis option exercisable within nbsp after meeting which compound were presented applicable within nbsp after meeting which result such additional activity presented curis select compound generated performance such plan such additional activity lead candidate without regard whether meet lead candidate criterion forth plan curis select such compound lead candidate within applicable period then unless otherwise agreed party writing program with respect applicable program target profile shall terminate style margin margin bottom text indent font size font family time roman event that despite conducting activity which responsible under particular plan using commercially reasonable effort generate development candidate applicable program aurigene shall promptly call meeting held within nbsp thereof which aurigene shall present relevant data information with respect program compound generated performance such plan shall discus good faith technical feasibility issue encountered aurigene effort generate development candidate such program target profile review target molecule profile under such plan consider whether amendment such plan whether provide aurigene perform additional activity modify target molecular profile forth therein otherwise necessary advisable party shall cooperate good faith with recommendation perform additional activity including more third party selected effort generate development candidate with cost borne agreed party such meeting within nbsp after completion such additional activity determined development candidate been generated select further activity undertaken effort generate development candidate then curis option period applicable program shall begin such date provided however that such option period expires unexercised within month after expiration such option period nbsp aurigene generates compound that been generated course applicable program would have been development candidate nbsp aurigene control such compound aurigene shall present such compound curis party shall discus good faith possibility resuming applicable program style margin margin bottom text indent font size font family time roman performance standard aurigene shall perform each program close collaboration with curis accordance with applicable plan term condition this agreement addition aurigene shall perform plan activity good scientific manner compliance with applicable style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman program cost style margin margin bottom text indent font size font family time roman subject curis issuance aurigene upfront equity issuance accordance with section nbsp aurigene performance program with respect delivery curis development candidate data package each shall aurigene sole cost expense style margin margin bottom text indent font size font family time roman except expressly forth subject curis payment when lead candidate selection milestone payment each accordance with section nbsp aurigene performance program with respect delivery curis development candidate data package each shall aurigene sole cost expense style margin margin bottom text indent font size font family time roman additional ptps except expressly forth subject curis payment when additional plan payment each additional program accordance with section nbsp aurigene performance additional program each additional delivery curis development candidate data package each additional shall aurigene sole cost expense style margin margin bottom text indent font size font family time roman development candidate data package with respect each program such time aurigene good faith belief that generated development candidate aurigene shall promptly present such development candidate designation such provide curis data information generated behalf aurigene with respect such prospective development candidate program compound development candidate data package during applicable option period such program aurigene shall make qualified aurigene representative reasonably available curis meeting otherwise discussion such development candidate data package each development candidate data package shall subject review determine whether such development candidate data package includes information with respect activity outlined agreed upon plan that proposed development candidate meet relevant target molecular profile criterion determines that such development candidate data package include such information shall unanimously identify necessary data information included such development candidate data package unanimously reach determination whether development candidate data package includes such information then then party shall submit matter independent third party expert with least year experience pharmaceutical industry practice with respect development pharmaceutical product resolution which expert shall agreed upon both party failing such agreement designated international centre dispute resolution located york city sole authority such expert will determine whether development candidate data package complete such expert determination shall final binding upon party independent third party expert shall required make determination within after selection independent third party expert party shall initially bear expense such expert equally prevailing party shall reimburse other party documented expense such expert paid prevailing party style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman disclosure result addition aurigene obligation deliver aurigene immuno oncology data package development candidate data package follow molecule profile data package accordance with section nbsp respectively aurigene shall keep curis regularly informed primarily progress result plan activity status patent filing with respect program invention style margin margin bottom text indent font size font family time roman follow molecule program target profile program target profile basis after curis exercise option with respect program particular program target profile prior expiration exclusivity period case exclusive program target profile extended exclusivity period aurigene shall disclose curis writing progress result aurigene research with respect follow molecule such program target profile provided that aurigene shall have obligation disclose information related chemistry such follow molecule that aurigene generated proposes generate until such time aurigene provides follow molecule data package applicable program target profile aurigene generates follow molecule data package such program target profile aurigene shall promptly deliver such follow molecule data package curis during applicable data package review period aurigene shall make qualified aurigene representative available curis meeting otherwise curis will have opportunity discus with request additional information extent available from such aurigene representative regarding follow molecule data package curis shall have until expiration applicable data package review period elect whether initiate program follow molecule applicable program target profile regardless curis decision whether initiate program follow molecule applicable program target profile aurigene exclusivity obligation with respect such program target profile shall remain effect until expiration exclusivity period long such program target profile subject active program case exclusive program target profile extended exclusivity period addition curis decide initiate program follow molecule applicable program target profile prior expiration data package review period then thereafter during exclusivity period case exclusive program target profile extended exclusivity period curis reasonable request reasonably advance next meeting aurigene shall present such next meeting then available data information regarding such follow molecule curis curis shall again have right initiate program follow molecule applicable program target profile style margin margin bottom text indent font size font family time roman record aurigene shall maintain complete accurate record work conducted performance each plan performance each follow molecule program conducted aurigene unless curis right under section nbsp with respect applicable program target profile have terminated expired unexercised result data invention development made performance such work such record maintained shall sufficient detail good scientific manner appropriate patent regulatory purpose upon reasonable prior written notice aurigene shall permit curis inspect such record shall provide copy requested record other than record style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman follow molecule program conducted aurigene with respect which curis right under section nbsp have terminated expired unexercised provided however that aurigene shall obligated permit curis inspect provide curis with copy record follow molecule program conducted aurigene until delivery curis follow molecule data package such follow molecule program provided further that aurigene delivers follow molecule data package follow molecule program conducted aurigene then aurigene shall permit curis inspect such record shall provide copy requested record such program promptly upon curis request time during applicable data package review period such follow molecule program curis shall maintain such record information contained therein confidence accordance with article nbsp hereof shall such record information except extent permitted this agreement aurigene obligation maintain record with respect work under plan program provide curis with access such record shall cease event that curis option with respect such program expires unexercised terminated prior exercise style margin margin bottom text indent font size font family time roman performance plan activity follow molecule research aurigene affiliate subcontractor aurigene shall have right perform plan activity conduct follow molecule discovery research through more affiliate third party subcontractor provided each case that nbsp none curis right hereunder diminished otherwise adversely affected result such delegation subcontracting nbsp each such affiliate subcontractor undertakes writing obligation confidentiality regarding confidential information least stringent those undertaken party pursuant article nbsp nbsp prior initiating performance plan activity follow molecule discovery research behalf aurigene each such affiliate third party subcontractor signed binding agreement instrument assigning agreeing assign aurigene data other work product resulting from performance such activity subject reasonable customary exception improvement applicable affiliate third party subcontractor font style white space nowrap existing font proprietary technology that performing such activity technology broad applicability that such affiliate third party subcontractor multiple product addition applicable program compound product provided each case that such improvement incorporate confidential information curis nbsp aurigene shall time fully responsible performance such affiliate subcontractor payment such affiliate subcontractor program target profile program target profile basis restriction aurigene right subcontract discovery research follow molecule particular program target profile affiliate third party subcontractor under this section nbsp shall cease event that curis right under section nbsp with respect follow molecule such program target profile expire unexercised terminated prior exercise style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign small rant small small small small ptions small small small small icenses small small xclusivity small small small table style margin margin bottom text indent font size font family time roman option grant style margin margin bottom text indent font size font family time roman program subject term condition this agreement with respect program each only subject curis payment when program selection milestone payment applicable program style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman target profile accordance with section nbsp program program basis with respect each program which designated program compound development candidate curis shall have aurigene hereby grant curis exclusive option obtain exclusive font style white space nowrap royalty bearing font license with right sublicense through multiple tier sublicense under aurigene technology develop make have made sell have sold offer sale import otherwise exploit program compound including development candidate back program compound product such program field curis territory each program option style margin margin bottom text indent font size font family time roman additional program option subject term condition this agreement additional program additional program basis with respect each additional program which designated program compound development candidate subject curis payment when additional plan payment such additional program accordance with section nbsp curis shall have aurigene hereby grant curis exclusive option obtain exclusive font style white space nowrap royalty bearing font license with right sublicense through multiple tier sublicense under aurigene technology develop make have made sell have sold offer sale import otherwise exploit program compound including development candidate back program compound product such additional program field curis territory each additional program option style margin margin bottom text indent font size font family time roman option exercise style margin margin bottom text indent font size font family time roman option period curis option with respect program shall exercisable time during period commencing delivery curis applicable development candidate data package such program applicable forth section nbsp applicable option period upon nbsp written notice exercise aurigene nbsp payment aurigene applicable option style margin margin bottom text indent font size font family time roman filing notwithstanding section nbsp curis determines that transaction contemplated herein subject then curis shall promptly event later than nbsp prior expiration option period notify aurigene writing such determination which event following shall apply style margin margin bottom text indent font size font family time roman soon reasonably practicable event later than nbsp after curis notifies aurigene such determination each curis aurigene shall file with federal trade commission department justice applicable notification report form certain merger acquisition that term defined relating transaction contemplated herein required curis shall responsible filing associated with such filing under pursuant except forth preceding sentence each party shall responsible cost expense incurs connection with preparation such filing performance other obligation under this section nbsp style margin margin bottom text indent font size font family time roman each curis aurigene shall nbsp promptly supply other party with information which required order effectuate such filing nbsp reasonable best effort promptly cause expiration termination applicable waiting style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman period under applicable foreign antitrust nbsp promptly supply additional information which reasonably required which party reasonably deem appropriate style margin margin bottom text indent font size font family time roman each curis aurigene will notify other party promptly upon receipt nbsp comment from official connection with filing made pursuant hereto nbsp request official amendment supplement filing made pursuant information provided comply material respect with style margin margin bottom text indent font size font family time roman option period such program including curis right exercise option such program shall extended until nbsp after earliest nbsp date upon which waiting period under expires terminates early nbsp date upon which closing letter received from case with regard transaction contemplated this agreement indicating that request have been satisfactorily objection part remains nbsp after filing received initial waiting period begin style margin margin bottom text indent font size font family time roman notwithstanding foregoing nothing this section nbsp shall require party propose negotiate effect agree sale divestiture license other disposition asset product line business otherwise take action that limit freedom action with respect ability retain business product line asset expend cost litigation part effort required style margin margin bottom text indent font size font family time roman license grant upon option exercise subject term condition this agreement program program basis effective automatically upon curis exercise option with respect program accordance with section nbsp prior expiration applicable option period same extended pursuant section nbsp hereof aurigene hereby grant curis exclusive font style white space nowrap royalty bearing font license with right sublicense through multiple tier sublicense under aurigene technology develop make have made sell have sold offer sale import otherwise exploit program compound including development candidate back program compound product such program licensed program field curis territory license style margin margin bottom text indent font size font family time roman curis license aurigene subject term condition this agreement licensed program licensed program basis with respect each licensed program effective automatically upon effectiveness license such licensed program aurigene shall have curis hereby grant aurigene exclusive font style white space nowrap royalty free font font style white space nowrap fully paid font license with right sublicense through multiple tier sublicense under curis technology make have made sell have sold offer sale import otherwise exploit program compound including development candidate back program compound product such licensed program field aurigene territory aurigene territory license clarity aurigene territory license excludes right make have made program compound product aurigene territory sale offer sale import distribute otherwise exploit program compound product curis territory style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman sublicensing style margin margin bottom text indent font size font family time roman generally sublicense granted curis sublicensee under license aurigene under aurigene territory license each case directly indirectly through such party affiliate third party shall nbsp writing nbsp commercially reasonable length term without intent circumvent other party right under this agreement case curis circumvent curis obligation compensate aurigene contemplated article nbsp provided that requirement this clause nbsp shall apply sublicense granted sublicensee nbsp subject consistent with term condition this agreement curis shall commercially reasonable effort include such sublicense agreement such consequence termination sublicensee sublicense applicable licensed program such sublicensee uncured material breach termination will such sublicensee that will nearly possible allow curis upon termination license such licensed program curis uncured material breach termination will curis provide aurigene with substantially same right with respect such terminated program would with respect curis technology such terminated program curis shall provide aurigene with copy sublicense agreement entered into curis affiliate sublicensee amendment thereto within nbsp execution aurigene shall provide curis with copy sublicense agreement entered into aurigene affiliate amendment thereto upon curis reasonable request provided that aurigene shall have right redact from such copy financial term such sublicense agreement each party shall notify other party writing within nbsp after nbsp termination sublicense agreement covering intellectual property right licensed under this agreement entered into such party affiliate nbsp learning termination sublicense agreement covering intellectual property right licensed under this agreement entered into sublicensee curis sublicensee curis technology aurigene each party shall responsible compliance affiliate sublicensees sublicensees applicable with applicable term condition this agreement style margin margin bottom text indent font size font family time roman sublicensing effort asia party acknowledge that asia accordingly after effective date party shall asia including effective date party asia party shall asia curis aurigene shall asia curis shall aurigene including curis aurigene shall asia aurigene curis shall consider good faith aurigene recommendation comment definitive agreement with asia partner shall subject section nbsp addition provision this section nbsp style margin margin bottom text indent font size font family time roman reserved right style margin margin bottom text indent font size font family time roman curis style margin margin bottom text indent font size font family time roman notwithstanding exclusivity aurigene territory license granted curis aurigene with respect licensed program curis hereby reserve font style white space nowrap exclusive font right under curis technology develop make have made sell have sold offer sale import otherwise exploit program compound product such licensed program field aurigene territory solely purpose development manufacture sale offer sale import exploitation program compound product such licensed program curis territory style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman curis hereby reserve exclusive right practice grant license under curis technology purpose other than purpose which aurigene been granted aurigene territory license hereunder style margin margin bottom text indent font size font family time roman aurigene style margin margin bottom text indent font size font family time roman notwithstanding exclusivity license granted aurigene curis with respect licensed program aurigene reserve font style white space nowrap exclusive font right under aurigene technology nbsp make have made develop sell have sold offer sale import otherwise exploit program compound product such licensed program field curis territory solely purpose development manufacture sale offer sale import exploitation program compound product such licensed program aurigene territory nbsp perform obligation under article nbsp hereof style margin margin bottom text indent font size font family time roman aurigene hereby reserve exclusive right practice grant license under aurigene technology purpose other than purpose which curis been granted license hereunder style margin margin bottom text indent font size font family time roman exclusivity style margin margin bottom text indent font size font family time roman collaboration scope subject section nbsp hereof during exclusivity period each party agrees work exclusively with other party manner contemplated under this agreement discovery research development molecule within immuno oncology with respect program target profile precision oncology style margin margin bottom text indent font size font family time roman exclusive program target profile subject section nbsp hereof during exclusivity period each extended exclusivity period which curis extended exclusivity each party agrees work exclusively with other party manner contemplated under this agreement each program target profile which there active program such program target profile exclusive program target profile style margin margin bottom text indent font size font family time roman additional exclusivity option extended exclusivity option style margin margin bottom text indent font size font family time roman additional exclusivity period subject term condition this agreement curis shall have aurigene hereby grant curis option extend exclusivity party collaboration contemplated section nbsp beyond initial exclusivity period year year basis three nbsp successive month period from expiration initial exclusivity period each additional exclusivity period paying aurigene applicable exclusivity option under section nbsp later than expiration applicable nbsp initial exclusivity period case first additional exclusivity period nbsp then current additional exclusivity period case each second third additional exclusivity period notwithstanding foregoing aurigene style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman fulfilled diligence obligation under section nbsp with respect each program during month period beginning effective date then initial exclusivity period shall automatically extended period time during which aurigene failed fulfill such diligence obligation exclusivity option extended exclusivity shall with respect such period style margin margin bottom text indent font size font family time roman extended exclusivity period time after exclusivity period whether curis elect exclusivity option with respect additional exclusivity period curis shall have aurigene hereby grant curis option further extend exclusivity party collaboration solely relates exclusive program target profile year year basis successive month period each extended exclusivity period paying aurigene exclusive program target profile exclusive program target profile basis extended exclusivity under section nbsp each extended exclusivity period later than expiration applicable nbsp either nbsp initial exclusivity period curis elect extend exclusivity additional exclusivity period nbsp last additional exclusivity period which curis exclusivity option curis elect extend exclusivity more additional exclusivity period nbsp then current extended exclusivity period case each subsequent extended exclusivity period style margin margin bottom text indent font size font family time roman eligibility additional exclusivity period extended exclusivity period during each additional exclusivity period curis shall obligated initiate least additional program eligible subsequent additional exclusivity period order curis exercise right obtain extended exclusivity period program target profile there must time when payment extended exclusivity such extended exclusivity period active program such program target profile style margin margin bottom text indent font size font family time roman exception exclusivity notwithstanding section nbsp contrary style margin margin bottom text indent font size font family time roman during exclusivity period extended exclusivity period aurigene shall have right research develop commercialize itself with more third party molecule claimed patent application product incorporating such molecule subject each case aurigene compliance with article nbsp hereof aurigene exclusivity obligation forth section nbsp shall apply such activity style margin margin bottom text indent font size font family time roman during exclusivity period extended exclusivity period aurigene shall have right discover research develop commercialize itself with more third party molecule product incorporating such molecule primary mechanism action which includes modulation aurigene exclusivity obligation forth section nbsp shall apply such activity style margin margin bottom text indent font size font family time roman aurigene nbsp aurigene provided that aurigene aurigene aurigene aurigene that aurigene curis under this agreement provision hereunder style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman during exclusivity period case exclusive program target profile extended exclusivity period aurigene shall have right conduct have contract research organization other contractor conduct aurigene behalf internal discovery research preclinical activity kind subject aurigene obligation curis right under this agreement including option license party respective right obligation under section nbsp excluding aurigene obligation curis right under section nbsp hereof style margin margin bottom text indent font size font family time roman during exclusivity period subject aurigene compliance with section nbsp curis select aurigene immuno oncology additional applicable conduct program prior expiration applicable data package review period then effective expiration such period aurigene exclusivity obligation under section nbsp shall cease apply solely with respect such aurigene immuno oncology style margin margin bottom text indent font size font family time roman curis timely exercise option particular program aurigene exclusivity obligation under section nbsp shall cease apply solely with respect program target profile that subject expired option style margin margin bottom text indent font size font family time roman event that after curis timely exercise option particular program license granted aurigene curis with respect such licensed program terminated accordance with article nbsp hereof aurigene exclusivity obligation under section nbsp shall cease apply solely with respect program target profile such former licensed program effective termination such license style margin margin bottom text indent font size font family time roman event that during period beginning curis exercise option program with respect particular program target profile ending upon expiration exclusivity period case exclusive program target profile extended exclusivity period curis grant sublicense under curis license with respect such licensed program sublicensee acquired third party acquirer that each case competing program with respect such program target profile then each case curis shall deemed have breached exclusivity obligation aurigene under section nbsp aurigene exclusivity obligation solely with respect such program target profile shall cease apply such program target profile shall cease exclusive program target profile purpose this agreement unless only long such sublicensee third party acquirer commercially reasonable effort mutatis mutandis develop pace that slower than pace development such competing program taking into consideration relative stage development such licensed program such competing program otherwise fulfill curis diligence obligation under section nbsp provided however that such sublicensee third party acquirer fails meet foregoing diligence obligation with respect such licensed program then without limiting other right remedy aurigene aurigene exclusivity obligation with respect such program target profile shall cease apply such program target profile shall cease exclusive program target profile purpose this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman event that during period beginning curis exercise option program with respect particular program target profile ending upon expiration exclusivity period case exclusive program target profile extended exclusivity period aurigene acquired third party acquirer that competing program with respect such program target profile then aurigene shall deemed have breached exclusivity obligation curis under section nbsp provided that such third party acquirer surviving entity such acquisition applicable continues fulfill aurigene diligence obligation under section nbsp with respect such licensed program style margin margin bottom text indent font size font family time roman curis terminates program prior exercise option aurigene exclusivity obligation under section nbsp shall cease apply solely with respect program target profile that subject program style margin margin bottom text indent font size font family time roman negative covenant style margin margin bottom text indent font size font family time roman curis curis hereby covenant practice permit cause affiliate sublicensee other third party practice aurigene technology purpose other than expressly authorized this agreement addition notwithstanding curis reserved right under curis technology curis covenant practice grant affiliate third party license practice curis technology purpose making having made program compound product curis territory sale offer sale import distribution other exploitation aurigene territory style margin margin bottom text indent font size font family time roman aurigene aurigene hereby covenant practice permit cause affiliate sublicensee other third party practice curis technology purpose other than expressly authorized this agreement addition notwithstanding aurigene reserved right under aurigene technology during period which curis hold license unexercised terminated option with respect particular program compound product aurigene covenant practice grant affiliate third party license practice aurigene technology purpose making having made program compound product aurigene territory sale offer sale import distribution other exploitation curis territory aurigene further covenant conduct nbsp enabling study program compound product from licensed program except expressly forth applicable development plan accordance with curis approved protocol such enabling study without curis prior written consent nbsp clinical trial program compound product from licensed program without curis prior written consent nbsp enabling study clinical trial follow molecule program target profile long aurigene exclusivity obligation with respect such program target profile effect except each case expressly permitted section nbsp style margin margin bottom text indent font size font family time roman implied license right license under patent right information granted shall granted implication such right license shall granted only expressly provided term this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign small evelopment small small anufacturing small small small small ommercialization small small small table style margin margin bottom text indent font size font family time roman development plan style margin margin bottom text indent font size font family time roman from after curis exercise option with respect program accordance with section nbsp party shall collaborate further development applicable development candidate with aurigene conducting enabling preclinical toxicology study support equivalent filing providing sufficient drug substance drug product support phase nbsp trial curis territory subject section nbsp curis having responsibility preparing equivalent application conducting further development activity each case more fully described this article nbsp promptly reasonably practicable after such option exercise curis shall prepare close consultation with aurigene deliver aurigene preliminary written preclinical development plan setting forth enabling study activity other enabling preclinical development activity that curis then anticipates will necessary filing with respect applicable development candidate based such curis shall development plan aurigene curis then including curis development plan clarity notwithstanding other provision this agreement contrary curis shall have development plan style margin margin bottom text indent font size font family time roman each development plan shall subject amendment update from time time follows style margin margin bottom text indent font size font family time roman that portion development plan setting forth activity which accordance with article nbsp provided however that curis style margin margin bottom text indent font size font family time roman prior subject curis amend that portion development plan setting forth activity which style margin margin bottom text indent font size font family time roman after prior nbsp curis amend that portion development plan setting forth activity which unless such amendment represents which case curis shall nbsp curis shall style margin margin bottom text indent font size font family time roman reasonable request with respect development plan including provided that this section nbsp intended shall style margin margin bottom text indent font size font family time roman used herein term development plan shall mean development plan then effect including recommended curis approved applicable update amendment thereto style margin margin bottom text indent font size font family time roman performance standard each party shall perform development plan activity which responsible accordance with applicable development plan term condition this agreement addition each party shall perform such development plan activity good scientific manner compliance with applicable applicable style margin margin bottom text indent font size font family time roman performance development plan activity aurigene affiliate subcontractor aurigene shall have right perform development plan activity style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman which aurigene responsible through affiliate third party subcontractor subject curis prior written approval third party subcontractor such approval unreasonably withheld provided however that nbsp nbsp reddy laboratory subsidiary hereby deemed approved curis purpose this section nbsp affiliate third party subcontractor that aurigene proposes nbsp been debarred under applicable including comparable applicable outside received notice pending action threat action with respect debarment nbsp used capacity service individual corporation partnership institution association which been debarred under applicable including comparable applicable outside then nbsp aurigene must seek prior written approval affiliate approved third party subcontractor nbsp shall unreasonable curis withhold approval affiliate third party subcontractor including each case nbsp reddy laboratory subsidiary provided further that nbsp none curis right hereunder diminished otherwise adversely affected result such delegation subcontracting nbsp each such affiliate subcontractor undertakes writing obligation confidentiality regarding confidential information least stringent those undertaken party pursuant article nbsp nbsp prior initiating performance development plan activity each such affiliate third party subcontractor signed binding agreement instrument assigning agreeing assign aurigene data other work product resulting from performance such activity subject reasonable customary exception improvement applicable affiliate third party subcontractor font style white space nowrap existing font proprietary technology technology broad applicability that such affiliate third party subcontractor multiple product addition applicable program compound product provided each case that such improvement incorporate confidential information curis including patent right other intellectual property right therein nbsp aurigene shall time fully responsible performance such affiliate subcontractor payment such affiliate subcontractor style margin margin bottom text indent font size font family time roman responsibility development commercialization curis territory style margin margin bottom text indent font size font family time roman curis responsibility from after curis exercise option with respect program except aurigene responsibility performing enabling preclinical development aurigene activity under section nbsp phase nbsp supply obligation under section nbsp curis shall solely responsible conducting development plan applicable development candidate otherwise developing registering commercializing program compound product field curis territory without limiting generality foregoing curis itself with through affiliate sublicensees shall solely responsible preparing submitting required regulatory filing connection with obtaining maintaining regulatory approval including inds ndas with respect program compound product each licensed program field curis territory curis sole expense curis curis curis shall compliance with applicable curis provided that nbsp aurigene party curis aurigene nbsp curis shall style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman aurigene responsibility each licensed program unless otherwise agreed party subject curis payment applicable option exercise under section nbsp aurigene shall responsible nbsp conducting nbsp enabling study applicable development candidate accordance with curis approved protocol nbsp aurigene activity with respect applicable development candidate accordance with applicable development plan nbsp other enabling preclinical development activity that applicable development plan specifies will responsibility aurigene each case accordance with applicable development plan nbsp providing sufficient drug substance drug product support phase nbsp trial curis territory subject section nbsp subject curis payment when milestone payment acceptance filing first product from each licensed program accordance with section nbsp applicable aurigene shall perform development plan responsibility phase nbsp trial supply obligation under section nbsp aurigene sole expense style margin margin bottom text indent font size font family time roman development aurigene territory each licensed program that terminated program aurigene pursue regulatory approval aurigene territory only specific product from such licensed program which curis pursuing obtained regulatory approval curis territory forth applicable development plan only same indication same dosage form formulation curis pursuing obtained regulatory approval curis territory such that aurigene will able data including curis data result generated conduct such development plan support filing regulatory approval with respect such product aurigene territory however applicable regulatory authority country aurigene territory requires aurigene reasonably belief that applicable regulatory authority country aurigene territory will require conduct particular enabling study clinical trial specific product which curis pursuing obtained regulatory approval curis territory same indication same dosage form formulation curis pursuing obtained regulatory approval curis territory which study trial expressly contemplated applicable development plan condition approving maintaining approval such product such country then aurigene conduct such enabling study clinical trial provided that aurigene provides curis written notice copy protocol such study least prior scheduled initiation such study considers good faith comment same received from curis during such period style margin margin bottom text indent font size font family time roman phase nbsp supply each program with respect which curis exercise option accordance with section nbsp aurigene shall manufacture have manufactured supply curis sufficient quantity drug substance drug product manufactured accordance with conduct phase nbsp trial applicable development candidate curis territory aurigene represents warrant that such development candidate drug substance drug product applicable will nbsp upon delivery curis conform applicable specification such drug substance drug product applicable effect time delivery nbsp have been manufactured compliance with applicable investigational drug nbsp free clear lien encumbrance notwithstanding anything contrary this section nbsp party through decide that drug substance drug product purchased curis from third party supplier curis expense style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman clinical commercial manufacture curis territory style margin margin bottom text indent font size font family time roman except phase nbsp trial material that aurigene responsible supplying pursuant section nbsp curis shall solely responsible manufacture supply clinical commercial product distribution curis territory with respect each program compound product subject section aurigene shall have option nominate primary global supplier such drug substance drug product supply option provided however that supply option shall subject applicable aurigene nominated supplier style margin margin bottom text indent font size font family time roman being competitive pricing quality production capacity capability other potential contract manufacturing organization provider drug substance drug product style margin margin bottom text indent font size font family time roman then operating compliant manufacturing facility which such drug substance drug product would manufactured style margin margin bottom text indent font size font family time roman having government permit including health safety environmental permit necessary operation such facility style margin margin bottom text indent font size font family time roman having received form nbsp notice foreign equivalent other regulatory authority refusal file rejection warning letter that been fully addressed such supplier satisfaction applicable regulatory authority style margin margin bottom text indent font size font family time roman nbsp being debarred under applicable including comparable applicable outside received notice pending action threat action with respect debarment nbsp using capacity service individual corporation partnership institution association which been debarred under applicable including comparable applicable outside style margin margin bottom font size font family time roman provided further that curis sublicensee third party acquirer applicable will have right establish second source drug substance drug product curis territory exceed total requirement while aurigene nominated supplier materially fulfilling obligation curis style margin margin bottom text indent font size font family time roman event that curis enters into sublicense agreement with third party with respect product curis will exercise commercially reasonable effort include supply option subject condition forth section nbsp such sublicense agreement party acknowledge that curis have power agree that curis required compel such sublicensee include supply option such sublicense agreement provided however that such event applicable royalty rate clause nbsp section nbsp shall increase with respect such sublicensee event this increase royalty rate under clause nbsp section nbsp result unreasonable economic style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman imbalance between party party shall meet attempt good faith eliminate otherwise modify this contemplated royalty increase maintain reasonable economic balance between party style margin margin bottom text indent font size font family time roman supply option subject condition forth section nbsp would survive permitted assignment this agreement curis pursuant section nbsp however applicable third party acquirer directly through affiliate nbsp substantial manufacturing capability wish manufacture product internally nbsp bona fide existing arrangement dating acquisition curis with that already been fully qualified third party acquirer standard global supply other product then shall breach this agreement such third party acquirer after considering good faith aurigene nominated global supplier applicable drug substance drug product that satisfies condition forth section nbsp make business decision contract with such aurigene nominated supplier supply such drug substance drug product provided however that such event applicable royalty rate section nbsp clause nbsp section nbsp shall increase event this increase royalty rate under section nbsp clause nbsp section nbsp result unreasonable economic imbalance between party party shall meet attempt good faith eliminate otherwise modify this contemplated royalty increase maintain reasonable economic balance between party clarity aurigene nominated supplier satisfy condition section nbsp then third party acquirer decision contract with such aurigene nominated supplier shall result increase royalty rate section nbsp clause nbsp section nbsp style margin margin bottom text indent font size font family time roman diligence style margin margin bottom text indent font size font family time roman aurigene licensed program licensed program basis aurigene directly through permitted affiliate subcontractor shall commercially reasonable effort perform obligation under development plan such licensed program expeditious manner style margin margin bottom text indent font size font family time roman curis licensed program licensed program basis curis directly through affiliate sublicensees shall commercially reasonable effort develop obtain regulatory approval commercialize least product within field each major market including each major market purpose this section nbsp commercially reasonable effort shall determined major market major market basis anticipated that level effort will different different major market change over time reflecting change status major market involved style margin margin bottom text indent font size font family time roman disclosure result style margin margin bottom text indent font size font family time roman enabling study aurigene activity aurigene shall deliver curis draft final study report each enabling study disclose curis result aurigene activity performed behalf aurigene under development plan each case promptly following availability thereof style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman other activity clinical trial curis shall nbsp disclose provide copy aurigene result activity other than aurigene activity performed behalf curis including activity preparation connection with nbsp disclose provide copy aurigene full table figure listing from deliver true complete copy final study report each study whether clinical otherwise program compound product conducted behalf curis each case promptly following availability thereof curis shall disclose provide copy aurigene other information data reasonably requested aurigene necessary useful manufacture development commercialization program compound product aurigene territory style margin margin bottom text indent font size font family time roman right access reference regulatory document licensed program licensed program basis with respect each licensed program effective filing first product from such licensed program major market curis hereby grant aurigene right access reference inds ndas submitted regulatory approval obtained from regulatory authority major market curis product from such licensed program collectively curis regulatory document each case solely purpose nbsp obtaining maintaining regulatory approval product from such licensed program field aurigene territory nbsp complying with applicable pharmacovigilance other regulatory requirement with respect such product aurigene territory curis shall promptly upon aurigene request file with applicable regulatory authority such letter access reference necessary accomplish intent this section nbsp style margin margin bottom text indent font size font family time roman safety data exchange each party shall solely responsible expense complying with applicable regulatory requirement with respect product such party territory including safety reporting regulatory authority such party territory party shall promptly upon reasonable request either party negotiate good faith enter into pharmacovigilance safety data exchange agreement product agreement which shall forth standard operating procedure governing collection investigation reporting exchange information concerning adverse drug reaction experience term agreement shall stringent than those required guideline shall sufficient permit each party comply with regulatory legal requirement management reporting safety data regarding such product providing exchange relevant information appropriate format within applicable timeframes curis shall responsible maintaining expense global safety database product from each licensed program style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign small inancial small small erms small small small table style margin margin bottom text indent font size font family time roman upfront equity issuance consideration nbsp aurigene performance plan development plan including delivery development candidate each such conduct enabling study aurigene activity each manufacture supply phase nbsp trial material each nbsp aurigene grant program option with respect each nbsp aurigene agreement exclusivity under section nbsp nbsp aurigene agreement continue research effort initiate program style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman effective date subject execution delivery aurigene stock purchase agreement curis shall issue aurigene number share curis common stock that represents outstanding share curis common stock immediately prior such issuance outstanding share curis common stock immediately after such issuance such percentage initial ownership percentage accordance with stock purchase agreement upfront equity issuance style margin margin bottom text indent font size font family time roman exclusivity style margin margin bottom text indent font size font family time roman exclusivity option each additional exclusivity period which curis elect extend exclusivity party collaboration contemplated section nbsp beyond initial exclusivity period curis shall aurigene later than applicable date specified section nbsp applicable forth below each exclusivity option style margin margin bottom text indent font size font family time roman first additional exclusivity period style margin margin bottom text indent font size font family time roman each second third additional exclusivity period style margin margin bottom text indent font size font family time roman extended exclusivity program target profile program target profile basis each extended exclusivity period which curis elect extend exclusivity party collaboration contemplated section nbsp program target profile beyond exclusivity period curis shall aurigene later than applicable date specified section nbsp month period each applicable program target profile each extended exclusivity style margin margin bottom text indent font size font family time roman program selection milestone payment within nbsp after recommendation curis selection applicable each conduct program curis shall aurigene time program selection milestone payment amount program clarity program selection milestone payment shall with respect style margin margin bottom text indent font size font family time roman additional plan payment with respect each proposed aurigene immuno oncology that recommends curis selects applicable additional conduct additional program curis agrees aurigene aggregate aurigene performance plan such additional program each such additional program additional plan payment which shall payable installment follows style margin margin bottom text indent font size font family time roman within nbsp after recommendation selection such additional style margin margin bottom text indent font size font family time roman within nbsp after lead candidate identification style margin margin bottom text indent font size font family time roman within nbsp after both nbsp aurigene delivers curis result enabling study aurigene activity other enabling preclinical development activity each case that aurigene responsible performing style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman under applicable development plan nbsp review such result confirms that result provided sufficient filing reason amount this section nbsp been paid time acceptance filing first such additional program then curis shall make such payment within such acceptance filing style margin margin bottom text indent font size font family time roman option exercise style margin margin bottom text indent font size font family time roman option exercise licensed program nbsp each licensed program nbsp licensed program nbsp licensed program nbsp licensed program nbsp only curis shall aurigene prior expiration applicable option period same extended pursuant section nbsp hereof time option exercise licensed program solely purpose this section nbsp licensed program nbsp refers first program with respect which curis exercise option licensed program nbsp refers second program with respect which curis exercise option licensed program nbsp refers third program with respect which curis exercise option licensed program nbsp refers fourth program with respect which curis exercise option provided however that curis exercise option with respect least program then licensed program nbsp shall mean third program with respect which curis exercise option licensed program nbsp shall mean fourth program with respect which curis exercise option additional program which curis exercise option considered licensed program nbsp licensed program nbsp applicable style margin margin bottom text indent font size font family time roman option exercise additional licensed program except expressly provided section nbsp curis shall aurigene prior expiration applicable option period same extended pursuant section nbsp hereof time option exercise each additional program with respect which curis exercise option style margin margin bottom text indent font size font family time roman milestone payment with respect each licensed program curis shall aurigene applicable time refundable creditable milestone payment forth below first achievement corresponding milestone event first product from such licensed program achieve such milestone event whether achieved curis affiliate sublicensee solely purpose this section nbsp nbsp licensed program nbsp licensed program nbsp licensed program nbsp licensed program nbsp refer first second applicable third fourth program respectively become licensed program provided however that curis exercise least option with respect program licensed program nbsp licensed program nbsp licensed program nbsp licensed program nbsp shall mean first second third fourth program respectively become licensed program they include additional program which curis exercise option nbsp additional licensed program refers additional licensed program other than licensed program nbsp clarity each milestone payment shall made only once licensed program style margin margin bottom text indent font size font family time roman licensed program nbsp within nbsp first achievement each milestone event forth table below first product from each style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman licensed program nbsp licensed program nbsp achieve such milestone event curis shall provide aurigene with written notice such achievement shall aurigene corresponding font style white space nowrap time font font style white space nowrap refundable font font style white space nowrap creditable font milestone payment forth below style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman milestone event valign bottom nbsp nbsp valign bottom colspan nowrap style border bottom solid width font size font family time roman milestone nbsp payment valign bottom nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman acceptance filing first valign bottom nbsp nbsp valign bottom valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman initiation first phase trial valign bottom nbsp nbsp valign bottom valign bottom align right nowrap valign bottom nbsp nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style line height margin margin bottom border bottom solid width nbsp valign bottom nbsp nbsp valign bottom valign bottom valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom valign bottom valign bottom table style margin margin bottom text indent font size font family time roman licensed program nbsp within nbsp first achievement each milestone event forth table below first product from each licensed program nbsp licensed program nbsp achieve such milestone event curis shall provide aurigene with written notice such achievement shall aurigene corresponding font style white space nowrap time font font style white space nowrap refundable font font style white space nowrap creditable font milestone payment forth below style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman milestone event valign bottom nbsp nbsp valign bottom colspan nowrap style border bottom solid width font size font family time roman milestone nbsp payment valign bottom nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style line height margin margin bottom border bottom solid width nbsp valign bottom nbsp nbsp valign bottom valign bottom valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom valign bottom valign bottom table style margin margin bottom text indent font size font family time roman additional licensed program within nbsp first achievement each milestone event forth table below first product from each additional licensed program achieve such milestone event curis shall provide aurigene with written notice such achievement shall aurigene corresponding font style white space nowrap time font font style white space nowrap refundable font font style white space nowrap creditable font milestone payment forth below subject section nbsp hereof style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman milestone event valign bottom nbsp nbsp valign bottom colspan nowrap style border bottom solid width font size font family time roman milestone nbsp payment valign bottom nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman development milestone event valign bottom nbsp nbsp valign bottom valign bottom valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman other milestone event valign bottom nbsp nbsp valign bottom valign bottom valign bottom bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style line height margin margin bottom border bottom solid width nbsp valign bottom nbsp nbsp valign bottom valign bottom valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom valign bottom valign bottom table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman reduction additional licensed program milestone payment amount payable curis achievement particular development milestone event forth section nbsp shall subject reduction applicable percentage forth below time such development milestone event achieved current defined below declined from initial ownership percentage initial current mean fraction expressed percentage with numerator equal number share curis common stock constituting upfront equity issuance adjusted stock split stock dividend combination recapitalizations redemption reverse stock split share buyback like with denominator equal total number share curis common stock outstanding time such development milestone achieved style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman percentage reduction from initial valign bottom nbsp nbsp valign bottom colspan align center style border bottom solid percentage nbsp reduction payment amount valign bottom nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style line height margin margin bottom border bottom solid width nbsp valign bottom nbsp nbsp valign bottom valign bottom valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom valign bottom valign bottom table style margin margin bottom text indent font size font family time roman royalty curis sale curis shall aurigene royalty aggregate annual sale each product curis affiliate except forth below sale such product sublicensees curis territory curis sale applicable rate forth below solely purpose this section nbsp first program market second program market third program market fourth program market refer first second third fourth licensed program respectively which there been first commercial sale product curis affiliate additional licensed program refers additional licensed program other than first program market second program market third program market fourth program market provided however that product product basis event neither style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman curis affiliate directly selling product least major market curis shall aurigene royalty aggregate annual sale such product united state sublicensees applicable rate forth below this section nbsp style margin margin bottom text indent font size font family time roman first second third fourth program market each first program market second program market third program market fourth program market curis shall royalty aggregate annual curis sale product from applicable licensed program each calendar year annual curis sale following rate style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman increment annual curis sale valign bottom nbsp nbsp valign bottom colspan align center style border bottom solid royalty nbsp rate valign bottom nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman that portion annual curis sale that than valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman that portion annual curis sale that greater equal than valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman that portion annual curis sale that greater than equal valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style margin margin bottom text indent font size font family time roman additional licensed program each additional licensed program curis shall royalty annual curis sale product from applicable licensed program each calendar year following rate style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman increment annual curis sale valign bottom nbsp nbsp valign bottom colspan align center style border bottom solid royalty nbsp rate valign bottom nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman that portion annual curis sale that than valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman that portion annual curis sale that greater equal than valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman that portion annual curis sale that greater than equal valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style margin margin bottom text indent font size font family time roman sharing sublicensee royalty licensed program licensed program sublicensee sublicensee basis curis shall aurigene applicable percentage forth below sublicensee royalty received curis from sublicensee with respect product from licensed program based nbsp geographic scope sublicense grant applicable sublicensee nbsp solely case sublicenses stage development most advanced product time sublicense granted applicable sublicensee solely purpose this section nbsp nbsp licensed program nbsp licensed program nbsp licensed program nbsp licensed program nbsp refer first second applicable third fourth program respectively become licensed program provided however curis exercise least option with respect program licensed program nbsp licensed program nbsp licensed program nbsp licensed program nbsp refer first second third fourth program respectively become licensed program they include additional program which curis exercise option nbsp additional licensed program refers additional licensed program other than licensed program nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman licensed program licensed program sublicensee sublicensee basis with respect sublicensee further sublicensees sale other disposition product from licensed program sublicensee sale curis shall aurigene greater nbsp applicable percentage sublicensee royalty specified below nbsp royalty sublicensee sale style margin margin bottom font size font family time roman align center licensed program nbsp licensed program nbsp style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width style font family time roman font size valign bottom rowspan nowrap style border bottom solid width font size font family time roman development stage most advanced product time sublicense grant valign bottom nbsp nbsp valign bottom colspan align center style border bottom solid greater valign bottom nbsp style font family time roman font size valign bottom nbsp nbsp valign bottom colspan align center style border bottom solid nbsp nbsp sublicensee royalty valign bottom nbsp valign bottom nbsp nbsp valign bottom colspan align center style border bottom solid nbsp nbsp sublicensee nbsp sale valign bottom nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman after earlier nbsp initiation first phase nbsp trial nbsp determination curis that human proof concept been established indication before initiation first pivotal trial valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman after initiation first pivotal trial valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style line height margin margin bottom border bottom solid width nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign subject nbsp deduction third party royalty accordance with section nbsp nbsp reduction accordance with section nbsp section nbsp nbsp each case section nbsp table style margin margin bottom font size font family time roman align center licensed program nbsp licensed program nbsp style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width style font family time roman font size valign bottom rowspan nowrap style border bottom solid width font size font family time roman development stage most advanced product time sublicense grant valign bottom nbsp nbsp valign bottom colspan align center style border bottom solid greater valign bottom nbsp style font family time roman font size valign bottom nbsp nbsp valign bottom colspan align center style border bottom solid nbsp nbsp sublicensee royalty valign bottom nbsp valign bottom nbsp nbsp valign bottom colspan align center style border bottom solid nbsp nbsp sublicensee nbsp sale valign bottom nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman after earlier nbsp initiation first phase nbsp trial nbsp determination curis that human proof concept been established indication before initiation first pivotal trial valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman after initiation first pivotal trial valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style line height margin margin bottom border bottom solid width nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign subject nbsp deduction third party royalty accordance with section nbsp nbsp reduction accordance with section nbsp section nbsp nbsp each case section nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center each additional licensed program style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width style font family time roman font size valign bottom rowspan nowrap style border bottom solid width font size font family time roman development stage most advanced product time sublicense grant valign bottom nbsp nbsp valign bottom colspan align center style border bottom solid greater valign bottom nbsp style font family time roman font size valign bottom nbsp nbsp valign bottom colspan align center style border bottom solid nbsp nbsp sublicensee royalty valign bottom nbsp valign bottom nbsp nbsp valign bottom colspan align center style border bottom solid nbsp nbsp sublicensee nbsp sale valign bottom nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman after earlier nbsp initiation first phase nbsp trial nbsp determination curis that human proof concept been established indication before initiation first pivotal trial valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman after initiation first pivotal trial valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style line height margin margin bottom border bottom solid width nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign subject nbsp deduction third party royalty accordance with section nbsp nbsp reduction accordance with section nbsp section nbsp nbsp each case section nbsp table style margin margin bottom text indent font size font family time roman rest curis territory curis shall aurigene sublicensee royalty received with respect sublicensee further sublicensees sale other disposition product from licensed program rest curis territory outside style margin margin bottom text indent font size font family time roman royalty sublicense revenue style margin margin bottom text indent font size font family time roman royalty sublicense revenue licensed program licensed program sublicensee sublicensee basis subject section nbsp curis shall aurigene applicable percentage forth below font style white space nowrap royalty font sublicense revenue received curis affiliate from sublicensee with respect grant sublicense licensed program font style white space nowrap nbsp royalty font sublicense revenue based stage development most advanced product time sublicense granted applicable sublicensee style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman development stage most advanced product time sublicense grant valign bottom nbsp nbsp valign bottom colspan align center style border bottom solid font style white space nowrap nbsp nbsp nbsp royalty font sublicense revenue valign bottom nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman after earlier nbsp initiation first phase nbsp trial nbsp determination curis that human proof concept been established indication before initiation first pivotal trial valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman after initiation first pivotal trial valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman royalty sublicense revenue style margin margin bottom text indent font size font family time roman curis shall aurigene font style white space nowrap royalty font sublicensing revenue received curis affiliate from asia partner regardless when such royalty sublicensing revenue received style margin margin bottom text indent font size font family time roman except forth section nbsp licensed program licensed program sublicensee sublicensee basis subject section nbsp curis shall aurigene applicable percentage forth below font style white space nowrap royalty font sublicense revenue received curis affiliate from sublicensee with respect grant sublicense licensed program rest curis territory outside asia font style white space nowrap font style white space nowrap asia nbsp royalty font font sublicense revenue based nbsp cumulative amount font style white space nowrap asia font font style white space nowrap royalty font sublicense revenue received nbsp whether font style white space nowrap font font style white space nowrap royalty font sublicense revenue received before after receipt first regulatory approval product from applicable licensed program country rest curis territory outside asia first font style white space nowrap asia font approval style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman time receipt font style white space nowrap asia font royalty sublicense revenue valign bottom nbsp nbsp valign bottom colspan align center style border bottom solid font style white space nowrap nbsp nbsp asia font font style white space nowrap royalty nbsp sublicense font revenue valign bottom nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman prior first asia approval valign bottom nbsp nbsp valign bottom valign bottom valign bottom style font family time roman font size valign style margin left text indent font size font family time roman first cumulative font style white space nowrap asia font font style white space nowrap royalty font sublicense revenue received valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman next cumulative font style white space nowrap asia font font style white space nowrap royalty font sublicense revenue received valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman font style white space nowrap asia font font style white space nowrap royalty font sublicense revenue received after first cumulative font style white space nowrap asia font font style white space nowrap royalty font sublicense revenue valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman after first asia approval valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style margin margin bottom text indent font size font family time roman treatment milestone payment additional licensed program solely case additional program that becomes licensed program curis receives milestone payment from sublicensee with respect achievement such sublicensee milestone event which curis obligated milestone payment aurigene under section nbsp then only that portion milestone payment received curis from such sublicensee that exceeds amount milestone payment curis obligated aurigene achievement such milestone event under section nbsp shall included font style white space nowrap royalty font sublicense revenue style margin margin bottom text indent font size font family time roman geographic allocation mechanism curis grant sublicense with respect licensed program more than nbsp nbsp asia nbsp more other country curis territory then font style white space nowrap royalty font sublicense revenue received from applicable sublicensee under such sublicense shall allocated amongst foregoing category country curis territory proportion respective percentage share total pharmaceutical market sale country covered such sublicense that style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman represented nbsp country category nbsp above that covered such sublicense nbsp country category nbsp above that covered such sublicense nbsp country category nbsp above that covered such sublicense each case reported health such other resource party mutually agree writing most recently available calendar year provided however that item font style white space nowrap royalty font sublicense revenue received under such sublicense that unequivocally tied particular country jurisdiction that entirely within only category nbsp category nbsp category nbsp above acceptance filing regulatory approval japan shall allocated solely such category nbsp applicable style margin margin bottom text indent font size font family time roman third party license style margin margin bottom text indent font size font family time roman event that curis affiliate sublicensee applicable required obtain more license under patent right third party reasonably necessary discussed below manufacture sale product country hereinafter third party license royalty actually paid under such third party license curis such affiliate sublicensee applicable sale such product such country calendar quarter will creditable against royalty payment aurigene curis with respect sale such product such country whether pursuant section nbsp applicable clause nbsp section nbsp provided however that event will royalty owed curis aurigene hereunder with respect sale such product such calendar quarter reduced more than provided further that curis will entitled credit portion royalty paid curis affiliate sublicensee third party with respect other active combination product style margin margin bottom text indent font size font family time roman purpose this section nbsp valid reason determining that license under patent right third party reasonably necessary manufacture sale product country shall limited following style margin margin bottom text indent font size font family time roman without practice invention claimed such patent right manufacture sale such product applicable product would commercially viable would likely materially profitable would achieve commercially reasonable level market acceptance such country style margin margin bottom text indent font size font family time roman absence license under such patent right such patent right would infringed manufacture sale such product such country style margin margin bottom text indent font size font family time roman promptly after curis affiliate enters into receives notice that sublicensee entered into third party license curis shall notify aurigene writing patent right covered such third party license aurigene good faith disagrees with determination curis affiliate sublicensee that such third party license reasonably necessary manufacture sale product country aurigene shall notify curis writing within nbsp after receipt such notice from curis whereupon party shall promptly confer regarding matter attempt good faith reach consensus nbsp from curis receipt such notice from aurigene party unable reach consensus within such period then party shall submit matter independent third party expert with relevant experience pharmaceutical industry practice style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman with respect licensing patent right connection with commercialization pharmaceutical product resolution sufficient experience background evaluate scope patent right validity enforceability under third party license whether reasonably necessary manufacture sale product country which expert shall agreed upon both party failing such agreement designated international centre dispute resolution located york city sole authority such expert will determine whether such third party license reasonably necessary manufacture sale such product such country such expert determination shall final binding upon party independent third party expert shall required make determination within after selection independent third party expert party shall initially bear expense such expert equally prevailing party shall reimburse other party documented expense such expert paid prevailing party style margin margin bottom text indent font size font family time roman compulsory license compulsory license granted third party with respect product country with royalty rate lower than applicable royalty rate under clause nbsp section nbsp then royalty rate applicable sale such product that country such compulsory licensee under clause nbsp section nbsp shall reduced rate which percentage point nbsp basis point than rate paid compulsory licensee provided however that royalty rate payable compulsory licensee with respect sale such product such country than then royalty rate under clause nbsp section nbsp shall reduced rate paid compulsory licensee only with respect sale other disposition product that country that compulsory licensee style margin margin bottom text indent font size font family time roman adjustment generic competition product product country country basis more generic version such product account more aggregate unit sale such product such generic version such country calendar quarter determined reference applicable sale data obtained from health from such other source such sale data agreed upon party provided that such other source shall generally recognized reliable source pharmaceutical sale data among major pharmaceutical company nbsp curis affiliate sublicensee grant right third party commercialize authorized generic product same product marketed without product trademark under same branded product where royalty rate payable third party sale other disposition authorized generic product lower than applicable royalty rate under clause nbsp section nbsp then royalty rate applicable sale such authorized generic product that country such third party under clause nbsp section nbsp shall reduced rate which percentage point nbsp basis point than rate paid third party provided however that royalty rate payable third party with respect sale such authorized generic product such country than then royalty rate under clause nbsp section nbsp shall reduced rate paid third party only with respect sale other disposition such authorized generic product that country that third party nbsp curis affiliate sublicensee reduces pricing applicable branded product applicable country such that royalty payable aurigene with respect such branded product such country result unreasonable economic imbalance between party party shall meet attempt good faith agree style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman modified royalty obligation curis maintain reasonable economic balance between party provided however that royalty rate payable such sublicensee with respect sale branded product such country than applicable royalty rate under clause nbsp section nbsp then royalty rate applicable sale branded product that country such sublicensee under clause nbsp section nbsp shall reduced rate which percentage point nbsp basis point than rate paid such sublicensee provided further that royalty rate payable such sublicensee with respect sale branded product such country than then royalty rate under clause nbsp section nbsp shall reduced rate paid such sublicensee only with respect sale other disposition such branded product that country such sublicensee style margin margin bottom text indent font size font family time roman royalty term royalty payment with respect sublicensee royalty shall payable product product country country basis from first commercial sale product country until later nbsp nbsp year from first commercial sale such product such country nbsp expiration last expire valid claim aurigene patent right claiming covering manufacture sale such product program compound contained therein such country royalty term provided however that during portion royalty term product country when there valid claim aurigene patent right covering manufacture sale such product program compound contained therein such country where requirement full royalty rate would render payment obligation unenforceable under applicable curis royalty payment obligation with respect curis sale such product such country curis minimum royalty payment obligation with respect sale such product sublicensees such country applicable shall reduced product product country country basis upon expiration royalty term with respect product country license with respect such product shall become royalty free fully paid irrevocable perpetual style margin margin bottom text indent font size font family time roman royalty floor except forth proviso section nbsp curis royalty payment obligation with respect curis sale product country curis minimum royalty payment obligation with respect sale product sublicensees country applicable shall reduced than payment that would otherwise reason deduction adjustment reduction that available under section nbsp clarity this section nbsp shall apply reduction pursuant section nbsp style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign small ayments small small ecords small small udits small small small table style margin margin bottom text indent font size font family time roman payment report royalty under section nbsp shall calculated each calendar quarter during royalty term paid within nbsp after calendar quarter payment under section nbsp shall calculated paid within receipt curis each such payment shall accompanied preceded report curis sale sublicensee royalty sale product sublicensees royalty sublicense revenue sufficient detail permit confirmation accuracy payment made including number product sold gross sale sale product itemized deduction from gross sale major category forth definition sale detail style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman royalty credit taken pursuant section nbsp third party patent license third party patent license basis applicable reduction adjustment made pursuant section nbsp section nbsp section nbsp amount payable exchange rate used each case product product country country basis provided however that case gross sale sale product sublicensee such sublicensee despite curis having used commercially reasonable effort obtain such sublicensee agreement under applicable sublicense agreement account report gross sale sale deduction from gross sale product product country country basis certain region account report deduction from gross sale itemized basis then each case curis report regarding such sublicensee gross sale sale deduction from gross sale need contain only same level detail that reported curis such sublicensee style margin margin bottom text indent font size font family time roman exchange rate manner place payment payment amount this agreement expressed dollar payment hereunder shall payable dollar when conversion payment from foreign currency required such conversion shall calculated applying average interbank exchange rate published oanda such other resource party mutually agree writing every within calendar quarter which payment payment owed under this agreement shall made wire transfer immediately available fund bank account designated writing aurigene style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman connection with upfront equity issuance style margin margin bottom text indent font size font family time roman curis agrees that upfront equity issuance shall made without setoff counterclaim free clear without deduction united state federal income such required withheld otherwise paid with respect upfront equity issuance curis shall timely such promptly possible thereafter send aurigene official receipt showing payment thereof together with such additional documentary evidence reasonably requested aurigene aurigene shall cooperate with curis reasonably requested curis obtain available reduction credit refund such without limiting generality foregoing upon request curis aurigene shall provide curis such information aurigene possession reasonably necessary curis obtain benefit applicable reduction present future treaty against double taxation which apply upfront equity issuance style margin margin bottom text indent font size font family time roman curis shall indemnify aurigene within after written demand therefor full amount paid aurigene that curis obliged deduct withhold under section nbsp penalty interest reasonable expense arising therefrom with respect thereto whether such were correctly legally imposed asserted relevant governmental authority certificate amount such payment liability delivered curis aurigene shall conclusive absent manifest error style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman connection with other payment aurigene style margin margin bottom text indent font size font family time roman aurigene will levied account payment made under this agreement other than upfront equity issuance imposed under republic india with respect transaction contemplated this agreement federal income required withheld curis from payment made aurigene under this agreement other than upfront equity issuance curis shall nbsp deduct such from payment made aurigene nbsp timely proper taxing authority nbsp send proof payment aurigene certify receipt taxing authority within nbsp following such payment nbsp cooperate with aurigene reasonably requested aurigene obtain available reduction credit refund such without limiting generality foregoing upon request aurigene curis shall provide aurigene such information curis possession reasonably necessary aurigene obtain benefit applicable reduction present future treaty against double taxation which apply payment made aurigene under this agreement style margin margin bottom text indent font size font family time roman aurigene shall indemnify curis within nbsp after written demand therefor full amount paid curis which aurigene liable under section nbsp penalty interest reasonable expense arising therefrom with respect thereto whether such were correctly legally imposed asserted relevant governmental authority certificate amount such payment liability delivered aurigene curis shall conclusive absent manifest error style margin margin bottom text indent font size font family time roman audit curis shall keep shall cause affiliate sublicensees extent applicable keep complete accurate record pertaining sale other disposition product sublicensee royalty royalty sublicense revenue each case sufficient detail permit aurigene confirm accuracy royalty revenue based payment under section nbsp least nbsp full calendar year following calendar year which they pertain aurigene shall have right cause independent certified public accountant international standing reasonably acceptable curis audit such record solely confirm curis sale sublicensee royalty sale product sublicensees royalty sublicense revenue royalty revenue based payment period covering more than preceding full calendar year calendar year shall subject audit under this section more than such audit exercised during normal business hour upon least nbsp prior written notice curis location where record maintained auditor will execute reasonable written confidentiality agreement with curis will disclose aurigene only such information reasonably necessary provide aurigene with information regarding actual potential discrepancy between amount reported actually paid amount payable under this agreement auditor will send copy report curis same time sent aurigene report sent both party will include methodology calculation used determine result prompt adjustment shall made party reflect result such audit aurigene shall bear full cost such audit unless such audit discloses underpayment curis more than amount calendar year under this agreement which case curis shall bear full cost such audit shall within remit aurigene amount underpayment late payment interest calculated pursuant section nbsp such audit discloses overpayment curis then curis will deduct amount such overpayment from amount otherwise owed aurigene under this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman late payment event that payment under this agreement made when payment shall accrue interest rate month period from date payment until date actual payment provided however that event shall such rate exceed maximum legal annual interest rate payment such interest shall limit aurigene from exercising other right have consequence lateness payment style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign small onfidentiality small small ublication small small small table style margin margin bottom text indent font size font family time roman confidential information except extent expressly authorized this agreement receiving party agrees that during term year thereafter shall keep confidential shall publish otherwise disclose third party shall purpose other than expressly provided this agreement confidential information disclosing party receiving party shall least same standard care protect proprietary confidential information event than reasonable care ensure that affiliate representative disclose make unauthorized confidential information receiving party shall promptly notify disclosing party upon discovery unauthorized unauthorized disclosure disclosing party confidential information style margin margin bottom text indent font size font family time roman exception confidential information shall include information which receiving party prove competent evidence nbsp hereafter becomes through failure part receiving party violation this article generally known available nbsp known receiving party affiliate time receiving such information other than being known result disclosure directly indirectly disclosing party evidenced record provided that exception this clause nbsp shall apply joint invention nbsp hereafter furnished receiving party affiliate third party matter right without restriction disclosure nbsp independently discovered developed receiving party style margin margin bottom text indent font size font family time roman affiliate without confidential information disclosing party style margin margin bottom text indent font size font family time roman authorized disclosure notwithstanding provision section nbsp receiving party disclose confidential information disclosing party expressly permitted this agreement extent such disclosure reasonably necessary following instance style margin margin bottom text indent font size font family time roman filing prosecuting patent right permitted this agreement style margin margin bottom text indent font size font family time roman enforcing such party right under this agreement performing obligation under this agreement style margin margin bottom text indent font size font family time roman prosecuting defending litigation permitted this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman complying with applicable court order applicable rule regulation listing rule exchange which receiving party security traded style margin margin bottom text indent font size font family time roman disclosure affiliate actual potential licensee sublicensees employee consultant agent receiving party have need know such information order receiving party exercise right fulfill obligation under this agreement provided each case that such affiliate actual potential licensee sublicensee employee consultant agent agrees bound term confidentiality comparable those forth this article nbsp style margin margin bottom text indent font size font family time roman disclosure third party connection with diligence similar investigation such third party disclosure potential third party investor confidential financing document provided each case that such third party agrees bound reasonable obligation confidentiality style margin margin bottom text indent font size font family time roman notwithstanding foregoing event receiving party required make disclosure disclosing party confidential information pursuant section nbsp will except where impracticable case requirement applicable court order applicable rule regulation under section nbsp nbsp give reasonable advance notice disclosing party such disclosure nbsp effort secure confidential treatment such information least diligent receiving party would protect confidential information event than reasonable effort nbsp cooperate with effort disclosing party disclosing party request expense secure confidential treatment such confidential information event receiving party agrees take reasonable action avoid disclosure confidential information hereunder style margin margin bottom text indent font size font family time roman publication style margin margin bottom text indent font size font family time roman program technology party proposes publish present material disclosing program technology such oral presentation manuscript abstract that party will communicate such intent patent team through alliance manager patent team shall first consider determine whether additional patent application claiming covering program technology proposed disclosed should made before party proposing make such publication presentation proceed consultation with patent team shall also discus good faith whether proposed publication presentation should made solely proposing party jointly party after determination that appropriate application program patent right have been filed with respect applicable program technology before such material submitted publication disclosure party proposing publication presentation publishing party shall deliver complete copy other party patent team least nbsp except case oral presentation material abstract which addressed below prior submitting material publisher initiating such other disclosure font style white space nowrap publishing font party shall review such material give their respective comment publishing party within nbsp delivery such material font style white space nowrap publishing font party which comment shall considered publishing party good faith with respect oral presentation material abstract publishing party shall deliver style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman complete copy font style white space nowrap publishing font party least nbsp prior anticipated date presentation font style white space nowrap publishing font party shall reasonable effort expedite review such material abstract shall return such item soon practicable publishing party with appropriate comment event later than nbsp from date delivery font style white space nowrap publishing font party which comment shall considered publishing party good faith publishing party shall comply with font style white space nowrap publishing font party request delete reference font style white space nowrap publishing font party confidential information other than applicable program technology such material font style white space nowrap publishing font party patent team identifies potentially patentable subject matter such material agrees delay submission publication other public disclosure period additional nbsp allow preparation filing appropriate patent application clarity requirement under this section nbsp with respect program shall cease event curis option with respect such program expires unexercised terminated prior exercise style margin margin bottom text indent font size font family time roman notwithstanding foregoing party agree that nbsp program technology from program shall published before earlier nbsp curis exercise option with respect thereto nbsp expiration applicable option period curis exercised such option prior such expiration unless mutually agreed party writing nbsp unpublished chemical structure program compound program target profile long aurigene exclusivity obligation with respect such program target profile effect shall published without unanimous recommendation applicable patent team style margin margin bottom text indent font size font family time roman clinical trial result clarity curis affiliate shall free publish authorize sublicensees publish result clinical trial product conducted behalf curis affiliate sublicensee without prior review approval aurigene style margin margin bottom text indent font size font family time roman publicity style margin margin bottom text indent font size font family time roman press release later than nbsp business following effective date party shall issue joint press release announcing execution this agreement substantially form attached hereto exhibit nbsp further acknowledged that each party desire required issue subsequent press release relating this agreement activity hereunder party agree consult with each other reasonably good faith with respect text timing subsequent press release prior issuance thereof provided that party withhold consent such release that other party determine based advice counsel reasonably necessary comply with applicable including disclosure requirement security exchange commission with requirement stock exchange which security issued party affiliate traded event required public announcement extent there sufficient time while still being able comply with applicable including disclosure requirement security exchange commission with requirement stock exchange which security issued party affiliate traded party making such announcement shall provide other party with copy proposed text such announcement sufficiently advance scheduled release afford such other party reasonable opportunity review comment upon proposed text each party make public statement regarding this agreement response question press analyst style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman investor those attending industry conference financial analyst call issue press release long content such public statement press release contained prior public disclosure public statement approved other party pursuant this section nbsp permitted section nbsp reveal font style white space nowrap public font information about other party style margin margin bottom text indent font size font family time roman filing this agreement party shall coordinate advance with each other connection with filing this agreement including redaction certain provision this agreement with security authority with stock exchange which security issued party affiliate traded each party will reasonable effort seek obtain confidential treatment term proposed redacted provided that each party will ultimately retain control over what term disclosed security authority stock exchange case extent such party determines advice legal counsel that disclosure reasonably necessary comply with applicable including disclosure requirement security exchange commission with requirement stock exchange which security issued party affiliate traded provided further that party will their reasonable effort file redacted version with governing body which consistent with redacted version previously filed with other governing body style margin margin bottom text indent font size font family time roman prior disclosure agreement effective date term this article nbsp shall supersede prior disclosure secrecy confidentiality agreement between party their affiliate dealing with subject this agreement including mutual supplemental confidential information disclosed party pursuant such prior agreement shall deemed confidential information such party purpose this agreement style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign small epresentations small small small small arranties small small small table style margin margin bottom text indent font size font family time roman mutual representation warranty each party represents warrant other that effective date nbsp duly organized validly existing under jurisdiction incorporation formation full corporate other power authority enter into this agreement carry provision hereof nbsp duly authorized execute deliver this agreement perform obligation hereunder person person executing this agreement behalf been duly authorized requisite corporate partnership action nbsp this agreement legally binding upon enforceable accordance with term conflict with agreement instrument understanding oral written which party which bound including with respect aurigene pierre fabre agreement violate material regulation court governmental body administrative other agency having jurisdiction over nbsp neither such party affiliate debarred under applicable including comparable applicable outside addition aurigene represents warrant curis that effective date neither aurigene affiliate nbsp conducting obligated conduct discovery research development with respect behalf collaboration with third party nbsp granted third party license option other right with respect compound primary mechanism action which modulation other than case right granted aurigene pierre fabre with respect molecule claimed patent application product incorporating such molecule style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman mutual covenant addition covenant made either party elsewhere this agreement each party hereby covenant other party follows style margin margin bottom text indent font size font family time roman neither such party affiliate will employ service person debarred under applicable including comparable applicable outside connection with activity relating program compound product event that such party becomes aware debarment threatened debarment person providing service such party affiliate with respect activity relating program compound product such party will immediately notify other party writing will cease cause affiliate cease applicable employing contracting with retaining such person perform service relating program compound product style margin margin bottom text indent font size font family time roman neither such party affiliate will connection with exercise right performance obligation under this agreement directly indirectly through third party promise offer authorize payment money give promise offer give authorize giving anything value public official entity purpose obtaining retaining business with directing business person including such party affiliate will such party affiliate directly indirectly promise offer provide corrupt payment gratuity emolument bribe kickback illicit gift hospitality other illegal unethical benefit public official entity other person otherwise violate anti bribery provision applicable connection with exercise such party right performance such party obligation under this agreement style margin margin bottom text indent font size font family time roman neither such party affiliate their respective employee contractor connection with exercise such party right performance such party obligation under this agreement shall cause other party violation fcpa export control style margin margin bottom text indent font size font family time roman such party shall immediately notify other party such party information suspicion that there violation fcpa export control connection with exercise such party right performance such party obligation under this agreement style margin margin bottom text indent font size font family time roman disclaimer except expressly forth this agreement technology intellectual property right provided each party hereunder provided except expressly forth this agreement each party expressly disclaims warranty kind express implied including warranty design merchantability fitness particular purpose validity patent infringement intellectual property right third party arising from course dealing usage trade practice style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman limitation liability except liability breach article nbsp neither party shall entitled recover from other party special incidental consequential punitive damage connection with this agreement license granted hereunder provided however that this section nbsp shall construed limit either party indemnification obligation under article nbsp style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign small ntellectual small small roperty small small small table style margin margin bottom text indent font size font family time roman ownership invention inventorship invention shall determined accordance with rule inventorship under patent aurigene shall solely aurigene invention curis shall solely curis invention party shall jointly joint invention clarity party intend program invention jointly owned party except with respect program invention that joint invention subject right obligation license granted under this agreement each party shall have right grant license joint invention joint patent right without other party consent duty account other party such license each party hereby waif right have under country require such consent accounting style margin margin bottom text indent font size font family time roman patent team later than recommendation plan each program party shall form patent team such program composed each party patent team with primary objective patent team shall applicable furthermore event patent team shall accordingly patent team addition patent team program shall responsible patent team activity with respect style margin margin bottom text indent font size font family time roman prosecution maintenance purpose this section nbsp term prosecution maintenance including variation such prosecute maintain shall mean with respect patent right preparing filing prosecution maintenance defense such patent right applicable jurisdiction well examination reissue request patent term extension like with respect such patent right together with conduct interference defense opposition other similar proceeding with respect patent right style margin margin bottom text indent font size font family time roman aurigene patent right style margin margin bottom text indent font size font family time roman prior option exercise program program basis prior curis exercise option program aurigene shall take lead prosecuting maintaining aurigene patent right including program patent right joint patent right relevant such program sole cost expense using outside counsel reasonably acceptable curis accordance with patent prosecution strategy recommended patent team such program aurigene outside patent counsel shall prepare proposed patent application close consultation with curis patent team representative curis outside patent counsel patent application other material patent office submission with respect such patent right will subject review comment curis outside patent counsel which comment shall considered good faith aurigene aurigene style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman plan make national phase filing country abandon such aurigene patent right particular country curis territory aurigene will notify curis writing least nbsp advance date payment other action that required prosecute maintain such aurigene patent right such country upon such notice curis shall have right obligation assume responsibility prosecution maintenance such aurigene patent right such country sole cost expense this section nbsp shall cease apply aurigene patent right that relevant program event curis option with respect such program expires unexercised terminated prior exercise style margin margin bottom text indent font size font family time roman after option exercise licensed program licensed program basis after curis exercise option program during term such license curis shall have first right obligation prosecute maintain aurigene patent right including program patent right joint patent right relevant such licensed program curis territory sole cost expense using counsel reasonably acceptable aurigene accordance with patent prosecution strategy recommended patent team such licensed program subject review comment from aurigene which comment shall considered good faith curis curis plan make national phase filing country abandon cease prosecution maintenance such patent right particular country curis territory curis shall notify aurigene writing least nbsp advance date payment other action that required prosecute maintain such patent right such country upon such notice aurigene shall have right obligation assume responsibility prosecution maintenance such patent right sole cost expense aurigene elect continue prosecution such patent right such country license granted curis under such patent right applicable under aurigene interest such patent right such country will terminated style margin margin bottom text indent font size font family time roman joint patent right except case joint patent right that subject section nbsp which shall governed solely section nbsp aurigene shall have first right obligation prosecute maintain joint patent right aurigene territory sole cost expense counsel choice curis shall have first right obligation prosecute maintain joint patent right curis territory sole cost expense counsel choice each case accordance with patent prosecution strategy approved patent team such joint patent each party shall keep other party reasonably informed progress with regard prosecution maintenance joint patent right which such party responsible party responsible shall consult with consider good faith request suggestion other party with respect strategy filing prosecuting joint patent right worldwide event that responsible party desire file desire abandon cease prosecution maintenance joint patent right country responsible party shall provide reasonable prior written notice other party such intention file abandon cease prosecution maintenance which notice shall extent possible given later than nbsp prior next deadline action that must taken with respect such joint patent right relevant patent office such case other party sole discretion upon written notice responsible party from other party other party elect continue prosecution maintenance such joint patent right sole cost expense counsel choice style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman cooperation party each party agrees cooperate fully prosecution maintenance patent right under section nbsp obtaining maintenance patent extension supplementary protection certificate like with respect thereto respectively cost such cooperation includes limited nbsp executing paper instrument requiring employee contractor execute such paper instrument effectuate ownership invention forth section nbsp patent right claiming disclosing such invention enable other party apply prosecute patent application country permitted section nbsp nbsp promptly informing other party matter coming such party attention that affect preparation filing prosecution maintenance such patent application style margin margin bottom text indent font size font family time roman infringement third party style margin margin bottom text indent font size font family time roman notice event that either aurigene curis becomes aware infringement threatened infringement third party aurigene patent right curis patent right joint patent right shall notify other party writing that effect style margin margin bottom text indent font size font family time roman aurigene patent right style margin margin bottom text indent font size font family time roman prior option exercise program program basis prior curis exercise option program neither party shall bring action proceeding against third party infringement aurigene patent right including program patent right joint patent right relevant such program without prior written consent other party determination proceed against such third party shall require mutual written agreement party this section nbsp shall cease apply aurigene patent right that relevant program event curis option with respect such program expires unexercised terminated prior exercise style margin margin bottom text indent font size font family time roman after option exercise licensed program licensed program basis after curis exercise option program curis shall have first right obligation bring control action proceeding against third party infringement aurigene patent right including program patent right joint patent right relevant such licensed program curis territory with respect infringing activity that competitive with program compound product expense counsel choice aurigene shall have right expense represented such action counsel choice curis fails bring such action proceeding within nbsp nbsp following learning alleged infringement nbsp nbsp before time limit forth appropriate regulation filing such action whichever come first then aurigene shall have right bring control such action expense counsel choice curis shall have right obligation expense represented such action counsel choice style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman curis patent right licensed program licensed program basis after curis exercise option program aurigene shall have first right obligation bring control action proceeding against third party infringement curis patent right relevant such licensed program aurigene territory with respect infringing activity that competitive with program compound product expense counsel choice curis shall have right expense represented such action counsel choice aurigene fails bring such action proceeding within nbsp nbsp following learning alleged infringement nbsp nbsp before time limit forth appropriate regulation filing such action whichever come first then curis shall have right bring control such action expense counsel choice aurigene shall have right obligation expense represented such action counsel choice style margin margin bottom text indent font size font family time roman joint patent right except case joint patent right that subject section nbsp which shall governed solely section nbsp nbsp aurigene shall have first right obligation bring control action proceeding with respect infringement joint patent right aurigene territory sole cost expense counsel choice curis shall have right expense represented such action counsel choice nbsp curis shall have first right obligation bring control action proceeding with respect infringement joint patent right curis territory sole cost expense counsel choice aurigene shall have right expense represented such action counsel choice party with first right bring control such action proceeding fails within nbsp nbsp following learning alleged infringement nbsp nbsp before time limit forth appropriate regulation filing such action whichever come first then other party shall have right obligation bring control such action expense counsel choice first party shall have right expense represented such action counsel choice style margin margin bottom text indent font size font family time roman cooperation award event party brings infringement action accordance with this section nbsp other party shall cooperate fully including required bring such action furnishing power attorney being named party neither party shall enter into settlement compromise action under this section nbsp which would manner alter diminish derogation other party right under this agreement without prior written consent such other party which shall unreasonably withheld except otherwise agreed party connection with cost sharing arrangement recovery realized party result action proceeding pursuant this section nbsp whether settlement otherwise shall retained party that brought controlled such action purpose this agreement provided however that each party shall reimbursed litigation expense recovery realized curis result action pursuant section nbsp after reimbursement party litigation expense with respect infringing activity curis territory shall treated sublicensee royalty applicable portion curis territory curis shall aurigene applicable percentage such recovery accordance with section nbsp calculated assuming time sublicense grant occurred date such recovery received style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman create party acknowledge agree that this agreement joint research agreement under create event that either party this agreement intends overcome rejection claimed invention within aurigene patent right joint patent right curis patent right pursuant provision create such party shall first obtain prior written consent other party party shall work together good faith agree rejection should overcome extent that party agree that order overcome rejection claimed invention within aurigene patent right joint patent right curis patent right pursuant provision create filing terminal disclaimer required advisable party shall first agree term condition under which patent application subject such terminal disclaimer patent application over which such application disclaimed shall jointly enforced extent that party have previously agreed such term condition style margin margin bottom text indent font size font family time roman patent term extension style margin margin bottom text indent font size font family time roman aurigene patent right licensed program licensed program basis after curis exercise option program curis shall have right determine aurigene patent right including program patent right joint patent right which will apply patent extension country region curis territory product from such licensed program curis shall file such extension curis cost expense aurigene shall provide reasonable assistance curis connection with such filing provided that curis shall reimburse pocket cost incurred aurigene providing such assistance style margin margin bottom text indent font size font family time roman curis patent right licensed program licensed program basis after curis exercise option program aurigene shall have right determine curis patent right which will apply patent extension country region aurigene territory product from such licensed program aurigene shall file such extension aurigene cost expense curis shall provide reasonable assistance aurigene connection with such filing provided that aurigene shall reimburse pocket cost incurred curis providing such assistance style margin margin bottom text indent font size font family time roman infringement third party right each party shall promptly notify other writing allegation third party that activity either party pursuant this agreement infringes infringe intellectual property right such third party neither party shall have right settle patent infringement litigation under this section nbsp manner that diminishes right interest other party without written consent such other party which shall unreasonably withheld style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign small small small small small ermination small small small table style margin margin bottom text indent font size font family time roman term term this agreement term shall begin effective date unless earlier terminated accordance with this article nbsp expire upon either nbsp nbsp after expiration research term curis exercised option with respect least program such time nbsp expiration last expire royalty term product style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman termination material breach style margin margin bottom text indent font size font family time roman material breach other than failure diligence subject section nbsp except case material breach covered section nbsp each party shall have right event material breach this agreement other party terminate this agreement entirety terminate this agreement part solely with respect affected program licensed program applicable upon written notice other party such other party material breach this agreement cured such breach within nbsp nbsp with respect payment breach after notice from terminating party requesting cure breach such termination shall become effective such with respect payment breach period unless breaching party cured such breach prior such period clarity event such uncured material breach affecting particular program licensed program such termination shall apply only affected program licensed program this agreement shall otherwise remain full force effect notwithstanding foregoing section nbsp contrary without limiting aurigene right under section nbsp after initiation first pivotal trial product licensed program aurigene terminate this agreement pursuant this section nbsp with respect such licensed program except case uncured material payment breach curis with respect such licensed program clarity aurigene pursue remedy that available equity result such breach curis notwithstanding foregoing section nbsp contrary after initiation first pivotal trial product licensed program curis terminate this agreement pursuant this section nbsp with respect aurigene territory license such licensed program clarity curis pursue remedy that available equity result such breach aurigene style margin margin bottom text indent font size font family time roman material breach diligence obligation style margin margin bottom text indent font size font family time roman material breach aurigene program program basis curis good faith belief that aurigene failed comply with obligation under section nbsp with respect program under section nbsp with respect licensed program curis shall notify aurigene within nbsp thereafter curis aurigene will meet confer discus matter good faith attempt agree upon mutually agreeable plan address issue related such failure aurigene following such meeting either nbsp party agree upon plan address such failure aurigene within foregoing period nbsp aurigene fails comply with obligation under mutually agreed upon plan address such failure aurigene then subject section nbsp below curis will have right sole discretion terminate this agreement relates such program licensed program applicable style margin margin bottom text indent font size font family time roman material breach curis program program basis aurigene good faith belief that curis failed comply with obligation under section nbsp with respect particular licensed program aurigene shall notify curis within nbsp thereafter curis aurigene will meet confer discus matter style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman good faith attempt agree upon mutually agreeable plan address issue related such failure curis following such meeting either nbsp party agree upon plan address such failure curis within foregoing period nbsp curis fails comply with obligation under mutually agreed upon plan address such failure curis then subject section nbsp below aurigene will have right sole discretion terminate this agreement relates such licensed program style margin margin bottom text indent font size font family time roman dispute regarding breach right terminate this agreement entirety with respect particular program licensed program applicable under this section nbsp shall stayed cure period tolled event that during cure period party alleged have been material breach shall have initiated dispute resolution accordance with article nbsp with respect alleged breach which stay tolling shall continue until such dispute been resolved accordance with article nbsp style margin margin bottom text indent font size font family time roman alternative curis termination aurigene material breach alternative terminating this agreement entirety relates particular program licensed program applicable pursuant section nbsp section nbsp aurigene uncured material breach clarity excluding licensed program after initiation first pivotal trial product such licensed program curis elect style margin margin bottom text indent font size font family time roman terminate this agreement entirety relates such program licensed program applicable style margin margin bottom text indent font size font family time roman retain right under this agreement entirety relates such program licensed program applicable including applicable option license with respect licensed program subject term condition hereof including article nbsp style margin margin bottom text indent font size font family time roman terminate nbsp case program with respect which option period expired aurigene right obtain aurigene territory license such program upon curis exercise option such program nbsp case licensed program aurigene territory license such licensed program style margin margin bottom text indent font size font family time roman terminate article nbsp section nbsp supply option such program licensed program style margin margin bottom text indent font size font family time roman assume sole responsibility development plan activity with respect such program licensed program including enabling study activity style margin margin bottom text indent font size font family time roman pursue remedy that available curis equity result aurigene breach without prejudice curis right terminate this agreement entirety relates such program licensed program applicable later date pursuant section nbsp section nbsp that uncured material breach long remains uncured other uncured material breach this agreement aurigene pursuant section nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman will termination curis curis shall have right terminate this agreement entirety relates particular program licensed program country country basis reason reason time upon nbsp prior written notice aurigene style margin margin bottom text indent font size font family time roman effect expiration upon expiration earlier termination this agreement license granted aurigene curis that were effect immediately prior such expiration shall survive exclusive royalty free font style white space nowrap fully paid font irrevocable perpetual basis style margin margin bottom text indent font size font family time roman effect termination style margin margin bottom text indent font size font family time roman termination prior option exercise event termination this agreement entirety prior curis exercise option program termination this agreement program prior exercise option such program then each case right license granted each party other party with respect such program under this agreement including option such program shall automatically terminate revert granting party style margin margin bottom text indent font size font family time roman effect termination fully paid license royalty term with respect product program country expired before termination this agreement entirety such program license with respect such product such country well applicable aurigene territory license shall survive such termination this agreement style margin margin bottom text indent font size font family time roman termination aurigene pursuant section nbsp curis pursuant section nbsp after option exercise solely event termination this agreement aurigene pursuant section nbsp section nbsp curis pursuant section nbsp following provision this section nbsp shall apply program that licensed program immediately prior such termination style margin margin bottom text indent font size font family time roman curis license with respect licensed program that terminated program either entire curis territory country curis territory outside terminated region applicable shall continue full force effect subject term condition hereof including article nbsp style margin margin bottom text indent font size font family time roman curis license with respect terminated program either entire curis territory terminated region applicable shall terminate revert aurigene style margin margin bottom text indent font size font family time roman curis shall hereby grant aurigene perpetual royalty free license with right sublicense under curis technology solely develop make have made sell offer sale have sold import otherwise exploit program compound product terminated program field either curis territory terminated region applicable such license shall exclusive with respect curis patent right exclusive with respect curis know notwithstanding foregoing extent curis patent right such terminated program include patent right licensed curis third party that subject royalty milestone payment obligation such third party with respect program compound product such terminated program then curis shall notify aurigene together with true complete correct description such royalty milestone payment style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman obligation inclusion such curis patent right license granted aurigene under this section nbsp such terminated program shall subject aurigene agreeing writing promptly paying royalty milestone payment that become such third party reason development manufacture commercialization such program compound product such terminated program behalf aurigene affiliate sublicensees curis territory terminated region applicable style margin margin bottom text indent font size font family time roman curis shall hereby grant aurigene right first negotiation exercisable within nbsp after termination obtain exclusive royalty bearing license with right sublicense under curis patent right solely develop make have made sell offer sale have sold import otherwise exploit program compound product terminated program field either curis territory terminated region applicable upon commercially reasonable term condition negotiated good faith party style margin margin bottom text indent font size font family time roman curis shall nbsp disclose aurigene soon reasonably practicable such curis technology with respect program compound product such terminated program previously disclosed aurigene necessary useful enable aurigene practice license granted under section nbsp applicable section nbsp nbsp promptly reasonably practicable transfer assign aurigene affiliate right title interest regulatory filing associated correspondence with regulatory authority with respect program compound product such terminated program either curis territory terminated region applicable applicable prevents delay transfer ownership such regulatory filing aurigene curis shall grant hereby grant aurigene exclusive irrevocable right access reference such regulatory filing program compound product from such terminated program either curis territory terminated region applicable shall cooperate fully make benefit such regulatory filing available aurigene designee nbsp take such other action execute such other instrument assignment document necessary effect transfer right under this section nbsp aurigene style margin margin bottom text indent font size font family time roman sublicense granted curis affiliate sublicensee under license with respect terminated program curis territory applicable terminated region applicable shall survive termination this agreement become direct license from aurigene such sublicensee provided that case termination curis uncured material breach pursuant section nbsp section nbsp such sublicensee cause such uncured material breach this agreement provided that aurigene shall have obligation under such sublicense beyond obligation expressly forth this agreement style margin margin bottom text indent font size font family time roman curis shall reasonably cooperate aurigene expense with aurigene designee facilitate smooth orderly prompt transition ongoing manufacturing development commercialization activity with respect program compound product terminated program aurigene designee curis territory applicable terminated region applicable style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman viii aurigene shall have right purchase from curis purchase price equal curis fully burdened manufacturing cost calculated accordance with accounting standard consistently applied available usable clinical commercial quantity product program compound terminated program curis affiliate possession control within nbsp after receipt aurigene request provided that curis retains license applicable licensed program portion curis territory curis shall obligated sell portion such supply that curis intends commercialize outside terminated region packaging transport insurance other cost delivery such purchased material aurigene designee shall paid aurigene style margin margin bottom text indent font size font family time roman product program compound terminated program being manufactured third party curis prior termination curis contract with vendor prior termination which contract necessary useful aurigene take over responsibility program compound product curis territory curis shall nbsp provide aurigene with introduction such third party contract manufacturer vendor nbsp deliver such contract manufacturer vendor written authorization contract with aurigene manufacture supply such product program compound manufacture supply such product program compound aurigene curis territory terminated region applicable using curis know possession such contract manufacturer such other service been provided curis with respect such product program compound curis territory terminated region applicable nbsp permitted agreement with such third party contract manufacturer vendor extent requested writing aurigene assign such agreement aurigene applicable work order statement work like under such agreement that relevant applicable product program compound assignment permitted cooperate with aurigene working with contract manufacturer vendor obtain benefit such agreement enter into agreement with contract manufacturer vendor negotiating agreement with third party contract manufacturer vendor service with respect program compound product curis shall commercially reasonable effort obtain agreement such contract manufacturer vendor permit curis assign such agreement applicable work order statement work like under such agreement that relevant applicable product program compound aurigene pursuant this section nbsp curis obtain such contract manufacturer vendor agreement foregoing curis shall commercially reasonable effort obtain such contract manufacturer vendor consent such assignment style margin margin bottom text indent font size font family time roman curis shall hereby grant shall cause granted aurigene license trademark specific more product program compound that curis affiliate sublicensee used with such product program compound curis territory terminated region applicable understood that such license shall include name curis affiliate sublicensees style margin margin bottom text indent font size font family time roman applicable aurigene territory license shall survive style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman return confidential information event termination this agreement each party shall return destroy directed other party data file record other material containing comprising other party confidential information except extent such confidential information necessary useful practice license aurigene territory license applicable that survives such termination accordance with section nbsp notwithstanding foregoing each party will permitted retain copy confidential information other party necessary comply with applicable purpose determining continuing obligation hereunder style margin margin bottom text indent font size font family time roman accrued obligation survival neither expiration termination this agreement shall relieve either party obligation liability accruing prior such expiration termination shall expiration termination this agreement preclude either party from pursuing right remedy have under this agreement equity with respect breach this agreement addition term provision this agreement which would reasonably expected survive expiration termination shall survive including party right obligation under section nbsp article nbsp this agreement shall survive expiration termination this agreement style margin margin bottom text indent font size font family time roman damage relief termination this agreement shall preclude either party from claiming other damage compensation relief that entitled hereunder style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign small ndemnification small small small table style margin margin bottom text indent font size font family time roman indemnification curis curis hereby agrees save defend indemnify hold harmless aurigene affiliate their respective officer director agent employee successor assigns aurigene indemnitees from against loss damage liability expense cost including reasonable legal expense attorney loss which aurigene indemnitee become subject result claim demand action other proceeding third party each claim extent such loss arise relate nbsp development manufacture handling storage sale offer sale import other disposition behalf curis affiliate sublicensees program compound product curis territory nbsp gross negligence willful misconduct curis indemnitee defined below nbsp breach curis warranty representation covenant agreement made curis this agreement except each case extent such loss result from gross negligence willful misconduct aurigene indemnitee breach aurigene warranty representation covenant agreement made aurigene this agreement style margin margin bottom text indent font size font family time roman indemnification aurigene aurigene hereby agrees save defend indemnify hold harmless curis affiliate their respective officer director employee consultant agent curis indemnitees from against loss which curis indemnitee become subject result claim demand action other proceeding third party extent such loss arise relate nbsp development manufacture handling storage sale offer sale import other disposition behalf aurigene affiliate licensee sublicensees program compound product aurigene territory other than such activity style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman pursuant development plan nbsp gross negligence willful misconduct aurigene indemnitee nbsp breach aurigene warranty representation covenant agreement made aurigene this agreement except each case extent such loss result from gross negligence willful misconduct curis indemnitee breach curis warranty representation covenant agreement made curis this agreement style margin margin bottom text indent font size font family time roman control defense event party indemnified party seek indemnification under section nbsp section nbsp shall inform other party indemnifying party claim soon reasonably practicable after receives notice claim being understood agreed however that failure indemnified party give notice claim provided this section nbsp shall relieve indemnifying party indemnification obligation under this agreement except only extent that such indemnifying party actually damaged result such failure give notice shall permit indemnifying party assume direction control defense claim including right settle claim solely monetary consideration using counsel reasonably satisfactory indemnified party shall cooperate requested expense indemnifying party defense claim indemnifying party assume control such defense within nbsp after receiving notice claim from indemnified party indemnified party shall control such defense without limiting indemnifying party indemnification obligation indemnifying party shall reimburse indemnified party cost including reasonable attorney incurred indemnified party defending itself within nbsp after receipt invoice therefor from indemnified party party controlling such defense participate therein expense party controlling such defense shall keep other party advised status such action suit proceeding claim defense thereof shall consider recommendation made other party with respect thereto indemnified party shall agree settlement such action suit proceeding claim without prior written consent indemnifying party which shall unreasonably withheld delayed conditioned indemnifying party shall agree settlement such action suit proceeding claim consent judgment respect thereof that include complete unconditional release indemnified party from liability with respect thereto that imposes liability obligation indemnified party that acknowledges fault indemnified party without prior written consent indemnified party style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign small ispute small small esolution small small small table style margin margin bottom text indent font size font family time roman dispute subject section nbsp claim dispute controversy breach enforcement interpretation validity this agreement each dispute will referred executive attempted resolution event such executive unable resolve such dispute within nbsp such dispute being referred them then upon written request either party other party dispute shall subject arbitration accordance with section nbsp except expressly forth section nbsp style margin margin bottom text indent font size font family time roman arbitration style margin margin bottom text indent font size font family time roman claim subject section nbsp below dispute that resolved under section nbsp within applicable period shall resolved final binding style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman arbitration administered international centre dispute resolution administrator accordance with then effective international dispute resolution procedure rule except extent such rule conflict with express provision this section nbsp capitalized term used otherwise defined this agreement shall have meaning provided rule arbitration shall conducted neutral arbitrator selected accordance with rule provided that such individual shall current former employee director current stockholder either party their respective affiliate licensee sublicensee right granted such party under this agreement shall have least year pharmaceutical industry experience arbitration associated discovery proceeding communication shall conducted english arbitration shall held york york aurigene request arbitration singapore curis request arbitration style margin margin bottom text indent font size font family time roman discovery within nbsp after selection arbitrator arbitrator shall conduct preliminary conference addressing subject within scope preliminary conference arbitrator shall take into account both desirability making discovery efficient cost effective need party understanding legitimate issue raised arbitration addition each party shall have right take nbsp hour deposition testimony including expert deposition testimony style margin margin bottom text indent font size font family time roman hearing decision hearing shall commence within nbsp after selection arbitrator arbitrator shall require that each party submit concise written statement position shall permit submission rebuttal statement subject reasonable limitation length such statement established arbitrator hearing shall longer than five business duration arbitrator shall also permit submission expert report arbitrator shall render award within nbsp after arbitrator declares hearing closed award shall include written statement describing essential finding conclusion which award based including calculation damage awarded arbitrator will rendering decision apply substantive state york excluding conflict principle with exception section nbsp york general obligation arbitrator authority award special incidental consequential punitive damage shall subject limitation forth section nbsp award rendered arbitrator shall final binding appealable judgment entered upon court competent jurisdiction style margin margin bottom text indent font size font family time roman cost each party shall bear attorney cost disbursement arising arbitration shall equal share cost arbitrator provided however arbitrator shall authorized determine whether party prevailing party award that prevailing party reimbursement reasonable attorney cost disbursement including example expert witness expense photocopy charge travel expense cost administrator arbitrator style margin margin bottom text indent font size font family time roman court action nothing contained this agreement shall deny either party right seek injunctive other equitable relief from court competent jurisdiction context bona fide emergency prospective irreparable harm such action style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman filed maintained notwithstanding ongoing discussion between party ongoing arbitration proceeding addition either party bring action court competent jurisdiction resolve dispute pertaining validity construction scope enforceability infringement other violation patent right other intellectual property right such claim shall subject arbitration pursuant section nbsp style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign small iscellaneous small small small table style margin margin bottom text indent font size font family time roman right upon bankruptcy right license granted under pursuant this agreement shall otherwise deemed purpose section nbsp title nbsp united state code other similar jurisdiction outside collectively bankruptcy license right intellectual property defined under bankruptcy case commenced during term against party under bankruptcy then unless until this agreement rejected provided such bankruptcy such party capacity including debtor possession successor assigns including trustee shall perform obligation provided this agreement performed such party case commenced during term against party under bankruptcy this agreement rejected provided bankruptcy other party elect retain right hereunder provided bankruptcy then party subject such case under bankruptcy capacity including debtor possession successor assigns including title nbsp trustee shall provide other party copy information necessary such other party prosecute maintain enjoy right under term this agreement promptly upon such other party written request therefor right power remedy bankrupt party provided herein addition substitution other right power remedy hereafter existing equity including bankruptcy event commencement case against party under bankruptcy style margin margin bottom text indent font size font family time roman governing this agreement shall governed construed accordance with state york excluding conflict principle with exception section nbsp york general obligation style margin margin bottom text indent font size font family time roman entire agreement amendment this agreement including exhibit hereto both final expression party agreement complete exclusive statement with respect term this agreement supersedes prior contemporaneous agreement communication whether oral written otherwise concerning matter contained herein including mutual supplemental exhibit this agreement incorporated herein reference shall deemed part this agreement this agreement amended term hereof modified only written instrument duly executed authorized representative both party hereto style margin margin bottom text indent font size font family time roman waiver failure party insist upon strict performance provision this agreement exercise right arising this agreement shall neither impair that provision right constitute waiver that provision right whole part that instance other instance waiver party particular provision right shall writing shall particular matter applicable particular period time shall signed such party style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman assignment except expressly provided hereunder neither this agreement right obligation hereunder assigned otherwise transferred either party without prior written consent other party which consent shall unreasonably withheld provided however that either party assign this agreement right obligation hereunder without other party consent style margin margin bottom text indent font size font family time roman connection with transfer sale substantially business such party which this agreement relates third party third party acquirer whether merger sale stock sale asset otherwise each sale transaction provided that event sale transaction whether this agreement actually assigned assumed third party acquirer surviving corporation resulting from such sale transaction operation context reverse triangular merger intellectual property right third party acquirer that existed prior sale transaction shall included technology licensed hereunder otherwise subject this agreement style margin margin bottom text indent font size font family time roman affiliate provided that assigning party shall remain liable responsible font style white space nowrap assigning font party hereto performance observance such duty obligation such affiliate style margin margin bottom text indent font size font family time roman right obligation party under this agreement shall binding upon inure benefit successor permitted assigns party name party appearing herein will deemed include name such party successor permitted assigns extent necessary carry intent this section assignment accordance with this agreement shall void style margin margin bottom text indent font size font family time roman force majeure each party shall excused from liability failure delay performance obligation under this agreement reason event beyond such party reasonable control including limited fire flood explosion earthquake other natural force civil unrest terrorism accident destruction other casualty lack failure transportation facility lack failure supply material strike labor disturbance other event similar those enumerated above such excuse from liability shall effective only extent duration event causing failure delay performance provided that party caused such event occur affected party shall notify other party such force majeure circumstance soon reasonably practical shall promptly undertake reasonable effort necessary cure such force majeure circumstance style margin margin bottom text indent font size font family time roman severability more provision contained this agreement held invalid illegal unenforceable respect validity legality enforceability remaining provision contained herein shall affected impaired thereby unless absence invalidated provision adversely affect substantive right party party shall such instance their best effort replace invalid illegal unenforceable provision with valid legal enforceable provision which insofar practical implement purpose this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman notice notice which required permitted hereunder shall writing sufficient delivered personally sent facsimile promptly confirmed personal delivery registered certified mail express courier sent internationally recognized express courier sent mail postage prepaid addressed follows style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign nbsp nbsp aurigene nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp valign bottom valign bottom aurigene discovery technology limited style font family time roman font size valign valign bottom valign bottom kiadb industrial area style font family time roman font size valign valign bottom valign bottom phase nbsp electronic city hosur road style font family time roman font size valign valign bottom valign bottom bangalore karnataka style font family time roman font size valign valign bottom valign bottom india style font family time roman font size valign valign bottom valign bottom attn murthy chief executive officer style font family time roman font size valign valign bottom valign bottom facsimile nbsp style font size height height colspan style font family time roman font size valign align right with nbsp nbsp copy nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp valign bottom valign bottom duane morris style font family time roman font size valign valign bottom valign bottom street suite style font family time roman font size valign valign bottom valign bottom diego style font family time roman font size valign valign bottom valign bottom style font family time roman font size valign valign bottom valign bottom attn david charapp style font family time roman font size valign valign bottom valign bottom facsimile nbsp style font size height height colspan style font family time roman font size valign curis valign bottom valign bottom curis style font family time roman font size valign valign bottom valign bottom nbsp maguire road style font family time roman font size valign valign bottom valign bottom lexington style font family time roman font size valign valign bottom valign bottom style font family time roman font size valign valign bottom valign bottom attn chief executive officer style font family time roman font size valign valign bottom valign bottom facsimile nbsp style font size height height colspan style font family time roman font size valign align right with copy nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp valign bottom valign bottom cooley style font family time roman font size valign valign bottom valign bottom eastgate mall style font family time roman font size valign valign bottom valign bottom diego style font family time roman font size valign valign bottom valign bottom style font family time roman font size valign valign bottom valign bottom attn jane adam style font family time roman font size valign valign bottom valign bottom facsimile nbsp table style margin margin bottom font size font family time roman such other address party whom notice given have furnished other party writing accordance herewith such notice shall deemed have been given nbsp when delivered personally delivered sent facsimile business delivered sent business then next business nbsp business after dispatch sent internationally recognized express courier nbsp fifth nbsp business following date mailing sent mail style margin margin bottom text indent font size font family time roman interpretation heading clause contained this agreement preceding text section subsection paragraph hereof inserted solely convenience ease reference only shall constitute part this agreement have effect style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman interpretation construction reference this agreement singular shall include plural where applicable term including includes used this agreement mean including without limiting generality description preceding such term word inclusive meaning represented phrase unless otherwise specified reference this agreement section shall include subsection paragraph such section reference this agreement subsection shall include paragraph such subsection reference this agreement shall mean calendar unless otherwise specified ambiguity uncertainty this agreement shall interpreted against either party irrespective which party deemed have caused ambiguity uncertainty exist this agreement been prepared english language english language shall control interpretation addition notice required permitted given hereunder written electronic oral other communication between party regarding this agreement shall english language style margin margin bottom text indent font size font family time roman relationship between party party relationship established this agreement solely that independent contractor this agreement create partnership joint venture similar business relationship between party neither party legal representative other party neither party assume create obligation representation warranty guarantee express implied behalf other party purpose whatsoever style margin margin bottom text indent font size font family time roman third party right provision this agreement exclusive benefit party other person entity shall have right claim against party reason these provision entitled enforce these provision against party style margin margin bottom text indent font size font family time roman counterpart this agreement executed counterpart each which shall deemed original document which together with this writing shall deemed instrument this agreement executed facsimile signature which signature shall have same force effect original signature style margin margin bottom font size font family time roman align center signature page follows style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman small small small itness small small hereof small party hereto have duly executed this collaboration option license agreement effective date style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width valign bottom width width style font family time roman font size valign colspan small urigene small small iscovery small small echnologies small small imited small small small valign bottom valign bottom colspan small uris small small small style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom valign bottom style margin margin bottom border bottom solid font size font family time roman murthy valign bottom valign bottom valign bottom valign bottom style margin margin bottom border bottom solid font size font family time roman fattaey style font family time roman font size valign name valign bottom valign bottom murthy valign bottom valign bottom name valign bottom valign bottom fattaey style font family time roman font size valign title valign bottom valign bottom valign bottom valign bottom title valign bottom valign bottom president table style margin margin bottom font size font family time roman exhibit index style margin margin bottom font size font family time roman exhibit press release style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center press release style margin margin bottom font size font family time roman align center incorporated reference exhibit company current report form filed with security exchange commission january nbsp body html text document